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VII 
ABSTRACT 
 
 
 The present work developed at Imperial College London (ICL) in collaboration with the 
Massachusetts Institute of Technology (MIT) had the objective of purifying the API amoxicillin 
containing an initial concentration of 30ppm of the compound 4-hydroxy-l-phenylglycine 
(impurity) using an OSN membrane cascade. 
 
 Project proposal: 
 Solubility and stability studies of the API in different solvents. 
 Solvent choice for the separation process. 
 Dissociation study of the API and impurity to exploit a promising optimization of the 
process. 
 Membrane screening using dead-end and m-CSTR upside-down measurements. 
 Process modeling and simulation of different configurations  
 
 Amoxicillin showed to be a sensitive compound to work with having a low solubility and 
a fast decomposition in the studied solvents. The solvents tested in detail were water, acetone, 
ethanol and methanol, being water the one choose to performed the purification. 
 
 From the dissociation study it was possible to understand the possible exploitation of 
the pH parameter in the optimization of the separation process. 
 
 In the membrane screening the effect of pressure and pH were studied in six types of 
membranes. It could be conclude that the main obstacle for the purification process was the 
membrane performance itself, with insufficient separation between the compounds (difference 
of 10 p.p. in rejection). The most promising results were obtained using the TFNF-DL 
membrane, with an API rejection of 99.12% and an impurity rejection of 87.80%.  
 
 The process modelling was performed in a semi-batch mode with one and two stages, 
respectively, and in continuous mode with two-stages and two different configurations. An 
increase from two to three stages was also analyzed for the continuous configuration II. A 
maximum purity of 99.65% with a yield of 97.86% was obtained with the semi-batch two-stage 
cascade system. From the continuous three stage cascade system, a purity of 98.65% and a 
yield of 98.54% were achieved. 
 
 
 
 
 
 
 
Keywords: Amoxicillin; Purification; Organic solvent nanofiltration (OSN); Active pharmaceutical 
ingredients (API); Membrane cascade 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
IX 
RESUMO 
 
 
 O presente projecto desenvolvido na Universidade Imperial de Londres (ICL) em 
colaboração com Instituto de Tecnologia de Massachussets (MIT) tinha como objectivo a 
purificação do API amoxicilina partindo de uma concentração inicial do composto 4-hydroxy-l-
phenylglycine (impureza) de 30 ppm recorrendo a nanofiltração com solventes orgânicos numa 
cascada de membrana. 
 
 Proposta de trabalho: 
 Estudos de solubilidade e estabilidade do API em diferentes solventes. 
 Escolha do solvente mais conveniente para à purificação. 
 Estudo da dissociação de ambos os compostos para explorar uma possível 
optimização do processo. 
 Testes de diafiltrações a diferentes membranas utilizando dead-end e m-CSTR. 
 Modelação e simulação do processo considerando diferentes configurações. 
 
A amoxicilina demonstrou ser um composto de difícil solubilidade e fácil decomposição. 
Os solventes testados em detalhe foram água, acetona, etanol e metanol, sendo água o 
solvente escolhido para proceder à purificação. 
 
 O estudo da dissociação iónica dos compostos demostrou a possível optimização do 
processo de separação através da exploração do parâmetro pH. 
 
 Na realização dos testes de diafiltração, o efeito da pressão e do pH foram estudados 
em seis tipos de membranas. Conclui-se que o principal obstáculo do processo de purificação 
seria o desempenho da própria membrana, pelo facto de nao efectuar uma separaracao 
eficiente entre os dois compostos (diferença de 10 p.p. entre rejeições). O resultado mais 
promissor foi obtido com a membrana TFNF-DL, tendo uma rejeição do API de 99.12% e uma 
rejeição da impureza de 87.80%. 
 
 A modelação do processo foi realizada a um sistema semi-continuo contendo uma 
única e duas etapas de separação; e ainda a duas configurações diferentes de um sistema em 
continuo com duas etapas de separação. Um aumento do número de duas para três etapas foi 
também analisado para a configuração II em contínuo. Uma pureza de 99.65% com um 
rendimento de 97.86% foi obtida usando o sistema semi-continuo com duas etapas de 
separação. Através do sistema de três etapas em contínuo, foi possível alcançar uma pureza 
de 98.65% com um rendimento de 98.54%. 
 
 
 
 
 
 
 
Palavras-Chave: Amoxicilina; Purificação; Nanofiltração com solventes orgânicos; Ingredientes 
farmacêuticos activos; Cascatas de membrana 
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IXX 
ABREVIATIONS 
 
 
 
API Active pharmaceutical ingredient 
CP Concentration polarization 
DCM Dichloromethane 
 DBB Dibromobutane 
 DBX Dibroxylene 
 DMAc N,N-dimetylacetamide  
FU Feed utilization ratio  
GTI Genotoxin impurity 
 HPLC High pressure liquid chromatography  
HPGM P-hydroxyphenylglycine methyl ester  
HVNC High value natural compounds 
IPA Isopropanol 
 ISA Integrally skinned asymmetric membranes  
m-CSTR Continuous single stirred tank reactor/membrane separator  
MeCN Acetonitrile 
 MEK Methyl ethyl ketone 
MF Microfiltration 
 MeOH Methanol 
  MW Molecular weight (g.mol
-1
) 
 MWCO Molecular weight cut-off 
NF Nanofiltration 
 NRe Reynolds number   
Nsh    Sherwoods number 
  NSc Schmidts number 
 
 
PEEK Poly(ether ether ketone) 
PEG 400 Polyethylene glycol 
 PFR Flow reactor  
 PGA Enzyme penicillin G acylase  
PI Polyimide 
  PP Polypropylene 
 Rc Rcycle ratio  
RO Reverse osmosis 
 TFC Thin-film composite membranes 
THF Tetrahydrofuran 
 UF Ultrafiltration 
 UV Ultraviolet 
 6-APA 6-aminopenicillanic acid  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
XXI 
NOMENCLATURE 
J Membrane flux (L.m
-2
.h
-1
) 
  R Rejection of the solute (%) 
 B Membrane permeability (L.m
-2
.h
-1
.bar) 
 C Concentration (g.L
-1
) 
  Cs,0 Solute concentration in the feed side (mol.m
-3
) 
Cs,p  Solute concentration in the permeate side (mol.m
-3
) 
A Membrane area (m
2
) 
 rP Pore size  
   ε surface porosity (dimensionless) 
  Ʈ 
 
Pore tortuosity (dimensionless) 
  ƞ 
 
Solvent viscosity (kg.m
-1
.s
-1
) 
  l Membrane thikness 
  K
L
 Solvent sorption  
  KS
L
 Solute distribution 
  D Fick’s law diffusion coefficient (m
2
.s
-1
) 
 R Gas constant (8.341 J.mol
-1
.K
-1
) 
k’ Mass transfer coefficient (m.s
-1
) 
 d Diameter (m) 
  D Diffusion coefficient (m
2
.s
-1
) 
 w Radial speed of the stir (rad.s
-1
) 
 ρ Density (kg.m
-3
) 
  μ Viscosity (Pa.s) 
  VAPI  API molal volume (cm
3
.mol
-1
) 
 ʋ Molar volume of the compound (m
3
.mol
-1
) 
F Flow rate (L.h
-1
) 
  Feed cell Feed into the first stage 
Feedin Fresh feed into the feed tank 
 Feedout Purified feed out of the feed tank 
Rc Recycle ratio 
  FU Feed utilization 
  t Time (h) 
   T Temperature (°C / K ) 
 V Volume (L) 
  P Pressure (bar/Pa) 
   
SUBSCRIPTS 
i Solute  
 R Retentate stream 
P Permeate stream 
FM Feed side liquid phase at the membrane liquid interface  
b Bulk 
 m Membrane surface 
v Volume 
 ∞ Limiting 
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1.1 Membrane Technology 
 
 Membranes have gained an important place in chemical technology and are used in a broad 
range of applications. This emerging technology has the potential to be applied in diversified industries 
such as the medical, pharmaceutical, wastewater, petrochemical and food. 
 
 A membrane is defined as a selective barrier between two phases which restricts the transport 
of some substances and allows the transport of others from one phase to another (Mulder, 1996). This 
transport trough the membrane takes place as a result of a driving force, i.e. by pressure, temperature, 
concentration or electrical potential difference, acting on the components in the feed. In addition to 
steric exclusion membrane-solvent interactions, pressure, feed concentration, temperature and charge 
can influence the membrane performance and such factors can hence be used to fine tune the 
separation (Mulder, 1996; Screewathanawut et al., 2010; Baker 2004). 
 
 1.1.1 Membrane types 
 
 A membrane can be homogeneous or heterogeneous, symmetric or asymmetric in structure, 
solid or liquid in terms of state and can be charged or neutral.  
 Membranes can generally be classified into biological membranes, or synthetic membranes 
which can be either organic (polymeric or liquid) or inorganic (ceramic, metal or zeolite) (Mulder, 
1996). Synthetic polymeric membranes are commonly classified according to their structure as 
symmetric or asymmetric. These two classes can be subdivided as shown in Figure 1.1. 
 
Symmetrical Membranes 
    
   Porous membrane      Dense membrane 
                 (nonporous) 
 
 
 
 
 
 
 
Asymmetrical Membranes 
    
  Integrally Skinned membrane  Thin Film Composite membrane  
     
   
 
 
  
 
 
 
Figure 1.1 – Schematic diagrams of the principal types of membranes (Adapted from Baker, 
2004). 
 
 The porous membranes are usually used in filtration processes, where separation is made by 
particle size. Nonporous membranes are frequently used in pervaporation and gas separation 
processes where the separation occurs according to the difference in solubility and diffusivity of the 
molecules in the membrane material. When these membranes are charged, they mostly separate by 
exclusion of ions of the same charge as the fixed ions of the membrane structure 
 
 Asymmetric membranes were a major breakthrough in the last decades. These membranes 
consist of an extremely thin surface layer supported on a much thicker porous structure, being the first 
layer the one that determinates exclusively the separation properties and permeation rates of the 
membrane whereas the porous sublayer functions, in conjunction with the backing material (such as 
polypropylene or polyester), as a mechanical support. With this technology it is possible to achieve, 
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unlike symmetric membranes, high selectivity with high transport rates, which brings a great 
economical advantage (Mulder, 1996; Screewathanawut et al., 2010). 
 
 The toplayer and its porous sublayer may be formed in a single operation, with the formation 
of integrally skinned asymmetric membranes (ISA), or separately, with the formation of thin-film 
composite (TFC) membranes. In TFC membranes the skin-layer and the porous sublayer can be 
made of different materials, which mean that the active layer and porous sublayer can be 
independently optimized to maximize the overall membrane performance. Nevertheless, the skinned 
asymmetric membranes have considerably lower manufacturing costs comparing to the TFC 
membranes (Mulder, 1996; Screewathanawut et al., 2010). 
 
 The interest in membranes formed from less conventional materials has increased. Ceramic 
membranes for example are being applied in microfiltration and ultrafiltration fields do to their superior 
performance in terms of chemical and thermal stability relative to polymeric membranes. This main 
class of inorganic membranes do not deform under pressure nor do they swell and are easier to clean, 
(cleaning agents such as strong acids and alkali, can be used). Furthermore, they have a greater 
lifetime than that of organic polymeric membranes. However, they tend to be more expensive and 
brittle than polymeric membranes and are also less versatile in applications. In addition, their large-
scale synthesis and module construction is not as easy as for polymeric membranes (Vandezande, 
Givers and Vankelecom, 2008). That is why the majority of membranes used commercially are still 
polymer-based (Mulder, 1996; Screewathanawut et al., 2010; Vandezande, Givers and Vankelecom, 
2008) 
 
 1.1.2 Membrane Processes 
 
 Membrane processes can be classified according to their driving forces. 
 
Table 1.1 – Classification of membrane processes according to their driving forces (Adapted 
from Mulder, 1996). 
Pressure 
difference 
Concentration 
difference 
Temperature  
difference 
Electrical potential 
difference 
Microfiltration Pervaporation Thermo-osmosis 
 
Electrodialysis  
Ultrafiltration Gas separation Membrane distillation 
 
Electro-osmosis 
Nanofiltration Vapour permeation - 
 
Membrane electrolysis 
Reverse Osmosis Dialysis - - 
 
Piezodialysis Difusion dialysis - - 
 Carrier-mediated 
transport  - - 
 
 
 The most important pressure driven membrane processes are microfiltration (MF), 
ultrafiltration (UF), nanofiltration (NF) and reverse osmosis (RO). All of them are used to concentrate 
or purify a dilute (aqueous or non-aqueous) solution. What differs between them is basically the size of 
the solutes to be separated. By changing the separation process from microfiltration to ultrafiltration, 
nanofiltration and reverse osmosis, the size (or molecular weight) of the particles or molecules 
separated diminishes and consequently the pore size in the membrane become smaller. This also 
implies that the resistance of the membranes to mass transfer increases and this is the reason why 
higher pressures are applied when changing the operation from microfiltration to reverse osmosis 
(Mulder, 1996). A comparison of the various pressure driven processes is given in Table 1.2. 
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Table 1.2 – Comparison of various pressure driven membrane processes. (Adapted from 
Coulston Vol.2, 2002) 
Microfiltration Ultrafiltration Nanofiltration and Reverse 
Osmosis 
Particle separation 
 
 
 
Pore sizes ≈ 0,05-10 μm 
Macromolecules separation  
(bacteria, yeast)  
 
 
Pore sizes ≈ 1-100 nm  
 
Separation of low MW 
solutes (salts, glucose, 
lactose, micropollutents) 
 
Pore sizes ˂ 2nm  
Low pressure applied         
(˂ 2 bar) 
Medium pressure applied                     
(1-10 bar) 
High pressure applied           
(≈ 10-60 bar) 
Separation based on the 
particle size 
Separation based on the particle 
size 
Separation based on 
differences in solubility and 
diffusivity 
 
 1.1.3 Membrane Characterization 
 
 Membranes can be characterized in terms of their performance and morphology. In terms of 
performance the most important parameters are flux, permeance, rejection, diffusion coefficients and 
separation factors. Morphological parameters include both physical (e.g. pore shape, pore size, pore 
distribution, membrane/top layer thickness, etc) and chemical parameters (e.g. charge, 
hydrophobicity, etc).  
 Performance parameters are dependent on morphological parameters, for instance pore size, 
shape and distribution have a big influence on the membrane flux. Depending on the pore size and 
shape the molecules will permeate easily or not (bigger pore sizes correspond to a better permeation 
and a higher flux) and if the pore distribution is uniform or not, membrane flux can be compromised 
due to fouling formation and pore blocking (non uniform pore distribution results in areas with higher 
flux than others promoting fouling in the less permeated areas). However, and despite the importance 
of characterizing and better understanding physical-chemical parameters, it is the functional 
parameters that from a practical perspective, determine the usefulness of the membrane (Mulherkar 
and Van Reis, 2004; Cuperus and Smolders, 1991). 
 The permeability rate, also denominated by flux, J (L.m
-2
.h
-1
), is defined as the volume of liquid 
permeating through the membrane (Vp) per unit of area (A) and time (t).  
 
 = 
V
P
A.t
 
           Equation I.1                                   
 
 Many parameters like temperature, pressure and solute concentration affect the flux of 
membranes. The permeate rate tend to increase with increasing temperature, because of reduction in 
solvent viscosity and increased polymer chain mobility (Van der Bruggen, Geens and Vandecasteele, 
2002). An increase in pressure also led to an increase in flux. Solute concentration has an adverse 
effect on flux because of osmotic pressure and concentration polarization. 
 
 Membrane selectivity can be expressed using the rejection coefficient, Ri. This coefficient is 
defined as the ability of the membrane to separate a solute i from the feed solution and it is usually 
given by, 
   ( 
     
      
    
)       (   
    
    
)       
           Equation I.2 
 
where CR,i and CP,i denotes the concentration of solute i at the retentate and permeate side, 
respectively. If a component has 100% rejection, none of it goes through the membrane; if a 
component has 0% rejection, all of it goes through the membrane. 
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 The selectivity can also be described by separation factor, α, when working with gas or 
organic solvent mixtures, being defined as the ratio between the coefficient of the concentrations of 
components A and B in the permeate, yA and yB, and the concentrations of the components in the 
retentate, xA and xB (Mulder, 1996). 
 
 Another important concept in the characterization of a membrane is the ‘molecular weight cut- 
off’ (MWCO), which represents the minimum molecular weight (MW) that is 90 % rejected by a 
membrane. This parameter, despite being useful as a starting point when screening for suitable 
membranes for a specific mixture separation, can be a poor estimation of the membrane performance. 
Pore size distribution, solvent environment, molecular shape, charge, functional groups, occurrence of 
polarization phenomena, temperature and the applied pressure are all factors that also affect the 
membrane rejection. (Mulder, 1996; Vandezande, Gevers and Vankelecom, 2008; See Toh et al., 
2007; Yang et al., 2001). 
 
 NF and OSN membranes are characterized by a sigmoidal rejection curve, as the ones 
depicted in Figure 1.2, and they can discriminate molecules with molecular weight in the range of 200 
to 2000 Da (Mulder, 1996; Vandezande, Gevers and Vankelecom, 2008). 
 
 
Figure 1.2 – Typical rejection curves for membranes with a sharp cut-off and a diffuse cut-off 
(Adapted from Mulder, 1996). 
 
 1.1.4 Transport in membranes 
 
 In order to understand and possibly predict fluxes and rejections for a certain membrane, the 
transport mechanism of solutes and solvents through porous or dense films of different membranes 
should be thoroughly understood. 
 
 Three groups of mathematical models are used to describe the transport through membranes: 
irreversible thermodynamics models, pore-flow model and solution-diffusion model. The most reliable 
and commonly used transport models are the pore-flow and the solution-diffusion models. They 
describe, respectively, the transport through porous (e.g. micro and ultrafiltration membranes) and 
dense membranes (e.g. reverse osmosis, gas separation and pervaporation membranes). 
 
   (A)      (B) 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3 – Schematic representation of the two transport mechanisms through membranes: 
(A) the pore-flow model and (B) the solution-diffusion model (Adapted from Baker, 2004).  
CHAPTER I –LITERATURE REVIEW 
FCT-UNL 
7 
 Pore-flow model 
 
 The pore-flow model assumes that different permeants are separated through tiny pores in the 
membrane by size-exclusion. This separation is accomplished by a pressure gradient across the 
membrane transporting the permeants through the pores. It is supposed that there are no 
concentration gradients, i.e. the solute and solvent concentration are constant over the membrane. 
Thus, the transport through porous membranes can be described based on hydrodynamic analysis by 
Darcy’s law (Equation I.3) in which k is the permeability coefficient, that contains membrane structural 
factors as membrane pore size (rp), surface porosity (ε), pore tortuosity (τ), solvent viscosity (η) and 
dP/dX is the pressure gradient over the membrane. 
      
  = k. 
dP
d 
= 
ε.rp
8.η.τ
 
dP
d 
 
           Equation I.3 
 Solution-diffusion model 
 
 The solution-diffusion was initially used to explain transport of gases across polymeric film and 
nowadays it became the most widely accepted explanation of membrane transport. This model 
assumes that permeants dissolve in the membrane material and then dissolve through the membrane 
due to a concentration gradient, while the pressure within the membrane is constant at the highest 
level. The separation between different permeants occurs due to differences in their solubilities and 
diffusivities (Baker, 2004). Following the assumptions made, two simple equations could be derived for 
volume and solute flux: 
 v=
D. L.C.v
l.R.T
 (ΔP Δ )=   (ΔP Δ ) 
           Equation I.4 
   
 s=
Ds. sL
l
 (Cs,0 Cs,p)=   (Cs,0 Cs,p) 
           Equation I.5 
 
where D and DS are the Fick’s law diffusion coefficients, K
L
 and KS
L
 are the solvent sorption and the 
solute distribution, respectively, C is the solvent concentration, v is the solvent molar flux, l is the 
membrane thickness, Cs,0 is the solute concentration in the feed side and Cs,p is the solute 
concentration in the permeate side; the constants Ba and Bs are known as the solvent and solute 
permeability, respectively (Baker, 2004). 
 
 OSN membranes are intermediate between truly porous and truly solution-diffusion 
membranes, and so they are best described by transient mechanisms that take into account the 
changing contributions of the diffusive and convective mechanisms, like the irreversible 
thermodynamics and the pore-flow models presented, or the solution-diffusion with imperfections 
model (Bhanushali et al., 2002), that accounts for the occurrence of convective flow and for the partial 
flux coupling effect. Plus, and since OSN membranes are applied to non-aqueous systems, special 
considerations regarding the various interactions between the system components and membrane 
swelling are also needed (Bhanushali et al., 2002; Boam and Nozari, 2006; Dijkstra Bach and Ebert., 
2006; Robinson et al., 2004). 
 
 1.1.5 Strengths and drawbacks in membrane processes  
 
 Compared with traditional separation processes as distillation or crystallization, membranes 
are an easy-to-operate and low-maintenance process. They can be easily installed as continuous 
processes and readily combined with existing processes into a hybrid process. The latter fact can be 
attributed to their modular set-up, which also renders upscaling relatively simple (Vandezande, Gevers 
and Vankelecom, 2008). These systems usually non-thermal and have low capital cost, compact size 
and power consumption, which reduce the production cost. Membrane technology also has a trend in 
being more energy efficient than the conventional techniques as well as being cleaner, therefore more 
environmentally friendly. Membrane processes are also extremely versatile, as membranes can be 
tailored to fit the most diverse applications like water purification, carbon capture and even organic 
solvent exchange. 
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 Membrane processes still have some limitations, that particularly slow down large-scale 
applications (Baker, 2004; Vandezande, Gevers and Vankelecom, 2008). The most relevant 
limitations are discussed in the following sub-sections. A special attention was given to problems 
related to pressure driven membrane processes, like NF and OSN. 
 
  1.1.5.1 Concentration Polarization 
 
 Concentration polarization (CP) is the accumulation of solutes at the membrane active layer 
surface as a result of a permeate flow through the membrane. It creates a higher solute concentration 
at the membrane surface compared with bulk. This phenomenon has greater effects in pressure-
driven processes due to high pressures used. In such processes CP leads to flux reduction due to 
increased pressure, that must be overcome, but also an increase in the driving force for the solute(s), 
reducing membrane selectivity. The increase in solute concentration at the membrane surface can 
also lead to a diffusive back flow towards the bulk of the feed, resulting in a concentration gradient 
between the bulk (Cs,b) and the membrane surface (Cm), creating a boundary layer which increases 
the resistance to mass transfer (Mulder, 1996). 
 
In the boundary layer: 
                                                v.Cs   Ds
dCs
dx
= v.Cs,p 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.4 – Concentration polarization: concentration profile under steady-state conditions 
(Adapted from Baker, 2004). 
 
 It is possible to minimize the concentration polarization effect by decreasing the boundary 
layer thickness. This can be achieved by increasing the fluid flow velocity past the membrane surface, 
by using membrane spacers, or by using pulsating flow, as all these options increase turbulent mixing 
at the membrane surface (Mulder, 1996; Baker, 2004). 
 
 It is known that concentration polarization increases exponentially with the volume flux, Jv. 
That is why after a certain pressure, the flux does not increase further on increasing the pressure and 
the so called limiting flux, J∞, is achieved. Thus, there is no point in having super-high-flux 
membranes, since the maximum flux will always be limited by osmotic pressure and concentration 
polarization. The only advantage of these membranes would be a reduction in energy costs, since 
they would allow for the same flux at lower applied pressure, minimize the overall processing time and 
limit the required membrane area (Mulder, 1996). 
 
 
 
 
 
Cs,m 
Cs,b 
Bulk feed 
Cs,p 
Permeate flux: Jv.Cs,p 
Membrane 
Boundary layer 
ᵟ 
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  1.1.5.2 Membrane fouling 
 
 Concentration polarization can result in membrane fouling, which is the deposition of retained 
solutes in the membrane, by adsorption, pore blocking, precipitation or cake formation. The type of 
separation problem and the type of membrane used in MF and UF make these processes the most 
susceptible to concentration polarization and fouling of all pressure driven membrane processes 
(Mulder, 1996). Fouling problems are, however, much more complex for NF processes, since the 
interactions leading to fouling take place at nanoscale, and are therefore difficult to understand (Van 
der Bruggen Mänttäri & Nyström., 2008). 
 One of the main consequences of membrane fouling is the decrease of flux. This has a 
negative impact on the operational costs of the process since the permeate production gets lower 
and/or higher trans-membrane pressures are required (Mulder, 1996).  
 Classical solutions to fouling are the pre-treatment of the feed and cleaning of membranes. 
Membrane design and process conditions can also be optimized to minimize fouling phenomena. 
Nevertheless, membrane modification is potentially the most sustainable solution, as it would allow to 
virtually avoid the problem (Mulder, 1996; Van der Bruggen Mänttäri & Nyström., 2008). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.5 – Effect of fouling and concentration polarization on flux (Adapted from Mulder, 
1996). 
 
  1.1.5.3 Insufficient separation 
 
 The incomplete separation is a major impediment for a wide application of membrane 
processes, including NF (Van der Bruggen Mänttäri & Nyström, 2008). 
 As mentioned before, membranes are characterized by a sigmoidal rejection curve which 
never is completely sharp. This will be translated in an insufficient separation between the different 
compounds on the basis of molecular size. A separation is dependent on other physical and chemical 
properties of the compounds and of the membrane, like charge (Bellona and Drewes, 2005), and 
since the pores of NF membranes follow a distribution of sizes (Richard Bowen and Doneva, 2000), 
the permeate usually contains molecules with variable sizes, both below and above the claimed 
average pore size of the membrane. The separation can be even more challenging for OSN 
processes, since solvents can change membrane characteristics, like pore size and hydrophobicity, 
and even solute characteristics, like solute effective diameter (Van der Bruggen Mänttäri & Nyström., 
2008; Geens et al., 2005). Therefore, a single membrane separation is often insufficient to obtain the 
desired separation (Van der Bruggen Mänttäri & Nyström., 2008). 
 There are different process strategies to overcome this problem, like multiple membrane 
passages, diafiltration or membrane cascades. As will be seen forward, membrane cascades offer 
further benefits, and begin to be considered for NF and OSN processes. 
 
 
 
 
 
 
 
 
 
 
Time 
Flux 
Concentration 
polarization 
Fouling 
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  1.1.5.4 Membrane compaction 
 
 Compaction is the mechanical deformation of a polymeric membrane matrix, due to the 
sealing and collapse of the pores at elevated pressures. Thus, this is a phenomenon which occurs 
specially with porous membranes used in pressure driven membrane operations, where the applied 
pressures are relatively high, like NF and RO (Mulder, 1996; See Toh et al., 2008). However, dense 
membranes tend also to suffer some compaction when exposed to swelling conditions (Vankelecom et 
al., 2004). This is never a problem for ceramic membranes due to their superior mechanical stability. 
 During compaction the flux declines until the membrane reaches a steady state in which no 
further permeate flux reduction occur. On the other hand, the rejection tends to increase, eventually 
stabilizes after a critical volume of solvent permeates through the membranes. After relaxation, the 
flux and rejection can return or not to its original value, depending on the reversibility of the membrane 
deformation (Mulder, 1996; Whu, Baltzis and Sirkar., 2000). In order to avoid this time dependent 
behavior, polymeric membranes should be pre-conditioned with pure solvent until a steady flux is 
obtained (Gibbins et al., 2002). 
 
  1.1.5.5 Membrane stability and lifetime 
 
 Membranes for industrial application require reproducibility performance as well as long-term 
stability and cleanability. 
 Lifetime and chemical resistance of nanofiltration membranes is related with the occurrence of 
fouling (therefore the need for cleaning) and the application of the membranes in demanding 
circumstances, such as the ones created by organic solvents (Van der Bruggen Mänttäri & Nyström., 
2008). 
 The cleaning regularity of the membranes is critical in aqueous applications. Even the mildest 
agents used in the cleaning process damaged the membrane to some extend and accelerate the 
deterioration process (Van der Bruggen Mänttäri & Nyström., 2008). 
 Compatibility of polymeric membranes with a wide range of organic solvents for solvent 
resistant nanofiltration is a new and even more challenging issue in discussions about membrane 
lifetime. Membranes can be made more stable by, e.g., increasing the degree of crosslinking of the 
polymeric top layer, by using alternative membrane materials. Ceramic membranes, as mention 
before, can be a solution to the swelling, changes in performance, and limited lifetime problems.  
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1.2 Membrane technology in the pharmaceutical industry  
 
 1.2.1 Drug production and purification  
 
 The manufacturing of a drug product involves two phases: the production of the API and the 
formulation process, in which the API is combined with one or more excipients to produce the final 
product. 
 A scheme of the different steps involved in a typical API synthesis process, including solvent 
waste streams generated in each step is shown on Figure 1.6. 
 
 
 
 
 
 
 
 
 
 
Figure 1.6 – Typical pharmaceutical batch operation (Adapted from Dunn, Wells and Williams, 
2010). 
 
 Most APIs are produced using liquid phase organic reactions which often require large 
quantities of different solvents. Since pharmaceutical legislation is very tight in relation to the impurity 
levels of the active compound, procedures of separation/purification have to be conducted. Between 
each reaction step, there are a series of operations required to separate, purify and isolate APIs 
intermediates (work-up phase). These steps frequently require more solvents and/or generate solvent 
waste. Because of the considerable number of steps and the large amount of solvents required per 
each step, solvent use can account for as much as 80-90% of the total mass in an API production 
process (Elin and Rundquist, 2012). 
 
 Crystallization and chromatography are the techniques of choice to isolate or purify materials 
such as API’s or HVNC’s (high value natural compounds). Precipitation and adsorption can also be 
used. 
 Crystallization is widely used for manufacturing specific, active ingredients during final and 
intermediate stages of purification and separation, and this process determines chemical purity and 
physical properties of active ingredients, such as crystal morphology, size distribution, and crystal 
structure (Myerson, 2002). These properties of crystalline solids can have important effects on their 
fluidity, filterability, tableting behavior, bioavailability, and stability (Myerson, 2002). Crystallization 
processes are regulated by both thermodynamic properties and crystallization kinetics, and 
understanding the crystallization processes is fundamental in better controlling and optimizing existing 
processes and designing new processes (Mullin, 2001). Nevertheless, during crystallization some 
concerns such as the scale-up, controllability of the process and the production of solute rich waste 
(mother liquors – impurities removed in the operation and API dissolved to the saturation limit) are 
observed.  
 In the case of chromatography, high consumptions of solvents and block issues in the 
stationary phase can be found (Screewathanawut et al., 2010; Elin and Rundquist, 2012; Justin Chun-
Te Lin, 2007). Many new green solvents or alternative reaction medium have been suggested for 
organic synthesis. Although their potential environmental and health risks are still unclear, they 
contribute as an alternative approach to decrease solvent consumption and reduce consequential 
pollution during organic synthesis processes. 
 Distillation is conventionally used in solvent exchange and in solvent recovery (approximately 
95% of all solvent separation processes) (Dunn, Wells and Williams, 2010), but it may not be ideal for 
API’s as many of them are thermally labile materials; also this operation consumes significant 
amounts of energy, generates significant quantities of intermediate solvent mixtures when used for 
solvent exchange (especially in a large scale) and inadequate condensing of distillate products (Justin 
Chun-Te Lin, 2007)  
Input(s)
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Spent solvent
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 Pharmaceutical industry is known to be relatively solvent intensive with high energy 
consumption. (Screewathanawut et al., 2010; Elin and Rundquist, 2012). It is essential that 
pharmaceutical companies reduce the overall environmental footprint, design even more efficient and 
robust processes, minimize solvent utilization, energy consumption and waste generation (Dunn, 
Wells and Williams, 2010). Membrane processes can be easily installed as a continuous process, and 
due to its modular set up, they can be combined readily with existing processes into hybrid processes. 
All these factors make membrane technology an attractive alternative (Vandezande, Givers and 
Vankelecom, 2008). 
 
 1.2.2 OSN process for API separation or purification 
 
 OSN has attracted a great deal of attention as an alternative process for purification of APIs as 
of HVNCs and also for recycle of solvents (Screewathanawut et al., 2010; Elin and Rundquist, 2012; 
Justin Chun-Te Lin, 2007; Stewart Slater, 2010).With recent introduction of stricter environment 
legislation, the expected price increase of the pure solvent and pressure from the regulatory agencies 
gives a chance to this technique (Stewart Slater, 2010; Siew et al., 2012).  
 
 Although OSN is still a relatively novel technology, it offers unique advantages over 
conventional separation methods. One of the benefits it is that the separation can be performed at 
near ambient or sub-ambient temperatures. This is a considerable advantage for thermolabile 
compounds, such as APIs and HVNCs that are susceptible to thermal degradation, minimizing the 
loss of activity, nutritive value and unwanted side-reactions. Other benefits associated are the energy-
efficiency, recovery of organic solvents with a purity suitable for re-use in API, reduced purchase of 
solvents, less storage and waste costs, increased compliance with environmental legislation and even 
reduced emissions of greenhouse gases (Screewathanawut et al., 2010; Elin and Rundquist, 2012). 
 
 In the field of purification and concentration of antibiotics and pharmaceutical intermediates, 
M. Kyburz, et all (2005) and X. Cao et all (2001) (Vandezande, Givers and Vankelecom, 2008) 
developed a post-synthesis recovery of 6-aminopenicillanic acid (6-Apa, 216 Da), an intermediate in 
the enzymatic manufacturing of synthetic penicillin, from its bioconversion solution with a Koch® 
membrane (commercial membrane MPS) (KOCH Membrane Systems Inc., 2013). With a recovery of 
90-95%, product loss was restricted to a minimum, leading to a pay-back time of less than one year. 
 A cross-flow microfiltration (MF) using Koch Membrane Systems (KMS) spiral wound elements 
has also been effectively employed as a replacement for traditional clarification methods to provide 
high product recovery with gentle processing conditions. For instance, in amino acid production older 
clarification technologies such as centrifugation and rotary vacuum filtration were substitute by KMS 
and with this system were possible to achieve yields as high as 98%. With KMS the improved and 
consistent filtrate quality will also simplify the downstream processing steps (KOCH Membrane 
Systems Inc., 2013). 
 
 Another example is the production of the antibiotic Spiramycin® normally extracted from 
bacterial broths with butyl acetate, which is traditionally recovered via evaporation, (has a negative 
influence on the quality of the final product). D. Shi et all (2006) (Vandezande, Givers and 
Vankelecom, 2008) developed a polyamide membrane for the concentration of this antibiotic, forming 
a mixture of three compounds with molecular weights between 830 and 800 Da. Rejections around 
99% and a much better product quality were achieved. 
  
 Recently a comparative study of flash chromatography and recrystallization, both conventional 
API purification technologies, versus OSN was performed by G. Székely et all (2012)
 
in order to 
evaluate the feasibility and sustainability of OSN as a potential API purification technology. Eleven 
GTIs and nine APIs of industrial interest were used as model compounds and various diafiltration 
studies were carried out. OSN was proven to be competitive and hence various solvent resistant 
nanofiltration membranes were screened in tetrahydrofuran (THF), methyl ethyl ketone (MEK) and 
dichloromethane (DCM). Using OSN technology, studies of the degenotoxification in the presence of 
various APIs of different chemical classes were also developed with success. 
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 OSN has been also applied to other innumerous processes such, continuous solvent 
exchange, solvent recycling and catalyst recycling. 
 
 Important applications in solvent exchange and recovery for pharmaceutical processes were 
also developed. Sereewatthanawut et al. (2010) proposed the utilization of a dual OSN membrane 
process for the recovery of THF during the diafiltration of an organic synthesis solution containing an 
API intermediate from Janssen Pharmaceutical, its isomer, and a series of oligomeric impurities based 
on the API intermediate (i.e., dimers, trimers, tetramers and pentamers). Using this process they were 
able to recover 99.2% of the product while reducing the overall content of impurities from 6.8 wt% to 
2.4 wt%, which is below the allowed limit of 3 wt % oligomeric impurities. They also claim that the 
integration of the solvent recovery stage allowed the reduction of the fresh solvent requirement by up 
to 90%. With the previous configuration, they proved that membrane technology can contribute 
towards a solvent-efficient process; such configuration does not generate large volumes of waste 
and/or does not provide a dilute product solution that would require further processing. 
 
 Rundquist, Pink and Livingston (2012) investigated the feasibility of using OSN as an 
alternative to distillation for solvent recovery from crystallization mother liquors. They observed that 
despite less solvent is recovered by OSN, this technique is capable of recovering organic solvent with 
suitable purity for re-use in subsequent API crystallizations and it uses 25 times less energy per liter of 
recovered solvent when compared to distillation. They also demonstrated that equivalent recovery 
volumes can be obtained by using an OSN hybrid process with the energy consumption remaining 9 
times lower than when distillation is used alone. 
 
 OSN has also been applied in the recycle of homogeneous catalysts. Nair et al (2001), 
permeated the post-reaction mixture through a polyimide OSN membrane achieving an overall 90% 
catalyst retention after four catalyst recycles (five reaction–filtration sequences) and a total catalyst 
turnover number (TON, moles of product synthesized per mol of catalyst added) of 1200.  
 
 Aerts et al. (2006) used silicon-based OSN membranes to recycle the Co-Jacobsen catalyst 
four times in diethylether (Et2O), achieving 98.5% retention and a minor decrease in the conversion 
from one cycle to another. 
 
 Recently, Peeva, Burgal and Livingston (2013) presented a continuous Heck coupling reaction 
combined with OSN separation of the catalyst in situ, using polymeric membranes (poly(ether ether 
ketone), PEEK) at high temperature (80ºC) and high concentration of base (>0.9 mol L
-1
). Two reactor 
configurations were investigated: a continuous single stirred tank reactor/membrane separator (m-
CSTR) and a plug flow reactor (PFR) followed by m-CSTR (PFR–m-CSTR). The combined PFR–m-
CSTR configuration was found to be the most promising, achieving conversions above 98% and high 
catalyst turnover numbers (TONs) of 20,000. In addition, low contamination of the product stream (27 
mg palladium per kg of product) makes this process configuration attractive for the pharmaceutical 
industry. 
 The application of OSN is still limited, despite a wide range of potential opportunities in the 
pharmaceutical and natural products industries. One of the main reasons for the slow technology 
breakthrough of the OSN membranes is the lack of robustness of commercially available membranes. 
Another issue is the mutual interactions between solute and solvent, solvent and membrane, as well 
as between solute and membrane that play a key role in addition to molecular pore size. This makes 
this process less accessible for the non-specialist, and renders selection of a suitable membrane type 
for a given separation relatively difficult. Adding to this, economical reasons and the long time that 
takes to update rules and considerations followed by the industries, slows the progression of these 
processes (Screewathanawut et al., 2010; Elin and Rundquist, 2012; Vandezande et al., 2007). 
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 1.2.3 Application of membrane cascade for API separation or purification 
 OSN membranes have made significant advance in terms of performance, but when working 
within the range of concentrations for APIs, it is unable to achieve total rejection (Screewathanawut et 
al., 2010; Elin and Rundquist, 2012). Insufficient discrimination between quite similar species is 
another obstacle that severely limits the industrial application of OSN when product purity is of high 
importance. In order to compete with conventional separation methods, such as chromatography, 
adsorption and crystallization, membranes must offer much better separation performance. 
 To improve the separation performance one might develop better membranes with superior 
performance, but an alternative is to modify the process configuration, for instance by using a 
membrane cascade. 
 
 The concept of membrane cascade dates back to the 1940s when it was first applied for 
uranium-235 (235U) enrichment using porous membranes (Mulder, 1996). A cascade consists in a 
series of separation units arranged in parallel (a stage/module). The simplest membrane process 
design is one in which a single module is used. However, the single-module design does not often 
result in the desired separation, since membranes are not always sufficiently selective (Van der 
Bruggen Mänttäri & Nyström., 2008). 
 
 There are two basic module configurations which are flat and tubular. The choice of the 
configuration should be based both on economic considerations and on the type of application 
(Mulder, 1996). Both configurations can be arranged either in parallel or in series in a cascade, 
according to the scale and the purpose of each application. The applications can be obtained by two 
filtration modes: the dead-end filtration mode in which the feed is forced through the membrane by a 
perpendicular pressure on the membrane surface; or the cross-flow filtration mode where the feed 
flows parallel to the membrane surface. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.7 – Schematic representation of membrane filtration system design: a) dead-end, b) 
cross-flow mode (Adapted from Arunima Saxena, 2009). 
 
 The main disadvantage of a dead end filtration is the extensive membrane fouling and 
concentration polarization. The tangential flow devices are less susceptible to fouling due to the 
sweeping effects and high shear rates of the passing flow. 
 
 There are other cross-flow operation modes where the feed and the permeate streams are 
parallel to each other, namely the concurrent and counter-current operation modes. It can be 
demonstrated by process calculations that the counter-flow gives the best separation results (higher 
driving force), followed by the cross-flow and co-current flow, respectively (Mulder, 1996). 
 Ultimately the module configuration in which the membrane is packed has a profound 
influence on its performance. The cascade system performance is determined by the separative 
capability inherent to the system and the properties of the feed and waste and in many cases the 
configuration has to be adapted to the requirements and limitations of the work system. 
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  1.2.3.1 Membrane configurations and modes of operation 
 Hwang laid the foundations of cascade theory in 1965 by applying the McCabe-Thiele method, 
originally developed for distillation, to the design of a membrane cascade for the separation of binary 
gas mixtures. This work showed the potential and the advantages of a well-designed membrane 
cascade system, with the ability to achieve any desired solute fractionation. Since then different 
schemes have been proposed by many authors. 
 
Feedin
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Figure 1.8 – General representation of the modules and units in a membrane cascade: P-
permeate; R- retentate; y – number of stages; n, p and z -number of membrane units in the first, 
second and y stage, respectively (Adapted from Siew et al., 2013). 
 
 Above is represented a configuration of stages and membrane units in a general multistage 
membrane process. In each stage the membrane units disposed in parallel have the same feed 
stream and similar permeate streams. On the other hand, the various stages are connected to each 
other in series, that is, each stage receives input from the previous one and passes its output on to the 
next stage. The number of units in each stage varies but when units have low capacity, it is necessary 
to use many units in parallel so large amounts of material can be processed (Krass, 1983; Benedict, 
Pigford and Levi, 1981; Villani and Becker, 1979). 
 
 In simple cascades, the stream that follows to the next cell is always a fraction of the feed. 
Consequently the final product stream amount decrease as the number of cells in the cascade 
increase. To overcome this problem one can use either cells of different size or a tapered-cascade 
arrangement (number of separating units decreases with each stage). A disadvantage of simple 
schemes is that these ones involve the discharge and no utilization of considerable material in 
discarded streams, so one should use such schemes only when relatively few stages are involved and 
if the disposed components are not fairly valuable (Villani and Becker, 1979; Hwang and 
Kammermeyer, 1975). However, the discarded streams can be recycled and passed back down as 
input to a preceding stage in a recycle cascade. 
 
 A recycling cascade has two sections: the enriching section, consisting of the stages above 
the point at which the feed enters the cascade and the stripping section below the feed point. The 
stripping section increases the recovery of the material, whereas the enriching section produces 
material of increased concentration. A simple cascade has only an enriching section. 
 In a symmetric cascade, the waste stream from each stage is recycled back to the 
immediately preceding stage. In an asymmetric cascade, the waste is recycled more than one stage 
back. A common asymmetric cascade feeds the product stream into the next stage and sends the tails 
stream back two stages back. This is called a two-up, one-down cascade (Olander, 1981). 
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 A very effective and common cascade design used is the symmetric countercurrent recycle 
cascade, which in some ways is very similar to a continuous distillation column (Benedict, Pigford and 
Levi, 1981). In the case of the countercurrent recycle cascade, the permeate of a stage feeds the next 
upper stage, while its retentate stream is recycled back to the immediately preceding stage (Villani 
and Becker, 1979). 
 
 A) 
P-100
P-92
  
 B) 
P-83
 
 
Figure 1.9 – Modes of cascade operation: A) simple symmetric cascade; B) symmetric 
countercurrent recycle cascade (Adapted from Siew et al., 2013). 
 
 The ideal cascade proposed by Hwang, assumes that the compositions of permeate and 
retentate streams that make up the feed to interior stages are kept constant, which means that there is 
no mixing of streams of different compositions between stages, and so there are no losses of 
separative work. To meet the no-mix criteria the flow rate between stages and the size of each stage 
must vary, which means that each stage has to be of different size. In addition, the feed is introduced 
within the cascade where the retentate composition is the same as the feed ( Hwang and 
Kammermeyer, 1965). 
  
 
 In spite of the fact that ideal cascades minimize the energy consumptions and the global size 
of the plant, its assembling is complicated in terms of design, fabrication, operation and maintenance 
(McCandless, 1990; McCandless and Herbst, 1990). The solution to this problem in practical terms of 
cascade design is to approximate the ideal cascade by a small number of squared cascade segments 
connected in series, in what is called a squared-off cascade. With this configuration, all of the stages 
can be made identical and so a large reduction in the cost of separative units can be achieved 
(McCandless and Herbst, 1990). 
 
 It was suggested by Lightfoot (2008), and verified by Siew et al. (2012), that the biggest 
challenge in cascade implementation is the delicate control of interacting flows. Inadequate control 
results in reduced separation efficiency, and can even lead to worse performance than a single-stage 
system. In addition, with an increasing number of membrane units, extra buffer tanks and pumps are 
usually required, complicating the process and increasing the initial capital cost. Thus, the theoretical 
advantages of membrane cascade diminish rapidly with an increasing number of units (Vanneste et 
al., 2012) Therefore, for a membrane cascade system to be practical, the number of cascade units 
must be minimized, the control of the system should be simple, and the system design should be easy 
to reconfigure for multiple operations. Simplicity and flexibility in process design should not be 
understated, as the versatility of equipment is considered vital to reducing capital expenditure in the 
pharmaceutical industry (Roberge et al., 2005; Székely et al., 2011). 
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  1.2.3.2 Membrane cascade applications 
 After the huge advance in membrane cascade theory during the 1940s (Mulder, 1996; Hwang 
and Kammermeyer, 1975; Halle and Shacter, 2000), a lot of authors started proposing different 
cascade schemes, derived from the countercurrent recycle cascade, for the separation of binary 
systems (McCandless and Herbst, 1990; Agrawal and Xu, 1996; Yan and Kao, 1989; McCandless, 
1985; Keureties et al., 1992). 
 
 Cascade design has been widely used not only for gas separation but also for liquid 
separation (McCandless, 1985) and solid fractionation (Vanneste et al., 2011)  
 Most of the studies on membrane cascades for the purification of liquid solutions are related to 
wastewater treatment. Several authors like Evangelista (1987) and Maskan et al. (2000) developed 
design methodologies to optimize RO network configurations and operating conditions. 
 Peng and Tremblay (2008) designed and tested a pilot scale membrane cascade system 
using MF, UF and NF membranes to remove oil and grease from bilge water accumulated in ships. 
The authors concluded that it is possible to reduce the oil and grease content of water to the allowable 
discharge limit through the proper design of the membrane system, selection of appropriate 
membranes, determination of optimal operating parameters, and assessment membrane 
performance.  
 The increasing need for a continuous, high-throughput, economical and easily scalable 
separation process for downstream processing of biological substrates, like proteins, carbohydrates, 
plasmids, viruses, organelles, and even whole cells, led Lightfoot (2005) to propose membrane 
countercurrent cascades as an alternative for chromatography and simulated moving bed 
chromatography. He and his co-workers also proposed (2008) an extended version of the binary ideal 
cascade theory for modeling diafiltration membrane cascades for fractionation of binary systems of 
two solutes in a single solvent. Each stage of a diafiltration membrane cascade consists of a UF 
module combined with a RO module to remove excess solvent from the permeate stream. 
 Lin, Peeva and Livingston (2006) were the first to propose membrane cascades for solute 
separation in an organic solvent environment. In their study they compared the performance of a 
three-stage OSN membrane cascade with recycle with the performance of a single OSN membrane 
module operating in diafiltration mode for API purification. Two dyes, Martius Yellow and Brilliant Blue 
R, were used as API product and color impurity, respectively. Both systems allowed to control the 
impurity level in the final product. However, the single-stage configuration showed better performance 
in terms of product productivity than the three-stage cascade (5.25 g·h
-1
·m
-2
 and 3.45 g·h
-1
·m
-2
 at the 
40th minute, respectively). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER I –LITERATURE REVIEW 
FCT-UNL 
18 
 
 
CHAPTER II – OBJECTIVES AND RESEARCH MOTIVATION 
FCT-UNL 
19 
 
 
 
 
 
 
 
 
 
     CHAPTER II 
    OBJECTIVES AND RESEARCH MOTIVATION 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER II – OBJECTIVES AND RESEARCH MOTIVATION 
FCT-UNL 
20 
  
CHAPTER II – OBJECTIVES AND RESEARCH MOTIVATION 
FCT-UNL 
21 
2.1 Amoxicillin purification via OSN 
 
 The present dissertation will focus on the separation of the API Amoxicillin (MW=365.40 Da) 
and the compound 4-hydroxy-L-phenylglycine (MW=167.16 Da), which is a sub-product of amoxicillin 
enzymatic synthesis, using an OSN membrane cascade,  
 
 
A) B) 
 
 
 
 
 
 
Figure 2.1 – Molecular representation of the studied compounds: A) Amoxicillin; B) 4-hydroxy-
L-phenylglycine. 
 
 Amoxicillin was one of several semisynthetic derivatives of 6-aminopenicillanic acid (6-APA) 
developed at Beecham company in the 1960s. It became available in 1972, and was the second 
aminopenicillin to reach the market (after ampicillin in 1961) (Raviña, 2011; Bruggink, 2001). 
 This moderate-spectrum, bacteriolytic, beta-lactam antibiotic is used to treat bacterial 
infections caused by susceptible microorganisms, such as ear infections, bladder infections, 
pneumonia, gonorrhea, and E. coli or salmonella infection. Can also be administrated to animals .This 
antibiotic is available in form of capsules, chewable and dispersible tablets, syrup and pediatric 
suspension for oral use and can even be found as a sodium salt for intravenous administration. 
 
 In spite of the availability of many new generation antibiotics, amoxicillin is still a popular drug 
in our days being one of the top drugs prescribed worldwide. It is one of the most prescribed 
antibiotics for children (Dave Mihalovic, 2012; Daniel DeNoon, 2012; IMS Health, 2012; Magalhães et 
al., 2012; Hiral Khoda, 2011; Fiona Aberdeen, 2012; Infobanc, 2009; Lai, 2009; Chandon, et al., 
2007). 
 In the year of 2012 were count around 53 million dispensed prescriptions of different brands of 
amoxicillin in the US 
1  and 2.9 million in retail pharmacies in Canada (IMS Health, 2012) 2; and in 
Brazil were sold more than 6 billion pharmaceutical units (pills) of amoxicillin, with sales of USD 780 
million, in the past 5 years (2007-2011). The growth in the mentioned period was about 10-20% per 
year (Magalhães et al., 2012). 
 In Europe, amoxicillin is one of the most used antibiotics in hospitals (Hiral Khoda, 2011); for 
example in France it accounts for 52% of the total percentage of antibiotics used in hospitals 
(considering the different formulations) (Fiona Aberdeen, 2012). 
 In India, between the years 2008-09, amoxicillin was estimated to have a market of 118 million 
USD, being the main exportations to South Africa, Nigeria, Myanmar, Sri Lanka and Netherlands. The 
growth in the mentioned period was in average 5% per year (Infobanc, 2009). 
 Since the patent from Beecham industry for the production of the API (by the name of 
Clamoxyl®) expired in 1980 (Lai, 2009; Chandon, et al., 2007), amoxicillin is marketed under many 
trade names, including Amoxil® (GlaxoSmithKline, UK), DisperMox® (Ranbaxy Laboratories, Inc., 
India), Moxatag® (Shionogi inc., China), Novamoxin® (TEVA., Canada), Trimox® (Sandoz - generic 
pharmaceuticals division of Novartis, Switzerland) and many others. 
  
 The future and need for beta-lactam antibiotics remains important; major pharmaceutical 
companies continue to have research and development efforts for new and improved beta-lactam 
biotechnology and chemistry. It is accurate to say that this antibiotic is very relevant in the 
pharmaceutical industry and that it has a solid and stable market and gives good signs of a continuous 
grow over the years. 
                                                          
1
 Total market of 4 billion (dispensed prescriptions)  
Includes all prescriptions dispensed through retail pharmacies - including independent and chain drug stores, food store 
pharmacies and mail order as well as long-term care facilities. Prescription counts are not adjusted for length of therapy. 90-day 
and 30-day prescriptions are both counted as one prescription. 
 
2
 Estimated prescriptions dispensed in retail pharmacies (excludes hospitals includes new and refills) 
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 2.1.1 Amoxicillin manufacturing and purification routes 
 Amoxicillin is mostly produced by chemical synthesis by adding an amino beta-lactam such as 
6-aminopenicillanic acid (6-APA), usually having its carboxyl group protected, with an activated side-
chain derivative followed by the removal of the protecting group by hydrolysis. 
In spite of the high yields that this process has achieved, it has been criticized for several 
disadvantages. These reactions typically involve costly steps, such as low temperatures (less than -
30ºC), and toxic organic solvents, such as methylene chloride and silylation reagents. In addition, high 
volumes of waste and byproducts have made this process undesirable (Alemzadeh, 2010; Falciani, 
1979; Grossman et al., 1975; Zang et al., 2010). 
 
 Due to the above mentioned disadvantages, the enzymatic synthesis of amoxicillin has 
become more interesting due to the increasingly tight environmental regulations. Enzymatic synthesis 
of beta-lactam antibiotics can be achieved by condensation of nucleophile and acyl donor through 
kinetic or thermodynamic controlled synthesis (Falciani, 1979). One of the most used, is the kinetically 
controlled synthesis of amoxicillin from P-hydroxyphenylglycine methyl ester (HPGM) and 6-amino 
penicillanic acid (6-APA), catalyzed by the enzyme penicillin G acylase (PGA). The use of enzymes, 
such as PGA, could be of great interest due to its high selectivity, specificity, and activity in mild 
reaction conditions (aqueous medium, neutral pH, and moderate temperatures) (Mitesh Shah, 2010; 
Grossman et al., 1975). 
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Figure 2.2 - Kinetically controlled synthesis of amoxicillin using penicillin G acylase as 
catalyst. (Adapted from Alemzadeh, 2010). 
 
 Figure 2.2 shows the kinetically controlled synthesis of amoxicillin from HPGM and 6-APA, 
which is conducted in an aqueous solution. Two side reactions, also catalyzed by PGA, compete with 
the synthesis of amoxicillin. Both side reactions lead to 4-hydroxy-l-phenylglycine, being the impurity 
present in our reaction mixture. Combining reactants and enzyme concentrations with pH and 
temperature conditions, it is possible to prioritize the main reaction, which is the production of 
amoxicillin. The optimized conditions for this reaction are: T= 35ºC, pH= 6.3, 20 mM 6-APA and 60 
mM HPGM (Mitesh Shah, 2010). It is possible to develop this enzymatic synthesis in other ways 
(Mitesh Shah, 2010; Shaohua Feng, 2006; Alemzadeh, 2010), but these will not be discussed in this 
study. 
 
 In the final formulation, normally is incorporated a beta-lactamase inhibitor, such as clavulanic 
acid, to avoid the antibiotic deactivation when in contact with gram-negative bacteria (Lai, 2009). 
 
 Since pharmaceutical legislation is very tight in relation to the impurity levels of the active 
compound, procedures of separation and/or purification have to be conducted carefully.  
Our objective is purifying a solution of amoxicillin containing 30ppm of 4-hydroxy-l-
phenylglycine using an OSN membrane cascade to achieve a concentration of our main impurity to a 
value equal or less than 3ppm.  
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 The separation and purification of this API consists in a series of steps, being crystallization 
one of most important steps in API purifications; in fact it is responsible for chemical purity and 
physical properties such as crystal morphology, size distribution, and crystal structure (Myerson, 2002; 
Mullin, 2001; Cai Shan-Ying, 2003). 
 This API is crystallized from aqueous solutions by the pH controlled crystallization method, 
and a recent patent claims that the bulk density, particle size distribution, and dissolution rate of 
crystalline amoxicillin powder can be improved by optimizing the crystallization conditions (Shaohua 
Feng, 2006)  
 It is easy to hydrolyze and degrade amoxicillin in acid and alkali solutions, and many 
degradation products are formed, including penicilloic acids and the dimer and trimer of amoxicillin 
(Chandon, et al., 2007). The existence of these degradation products not only reduces the yield of the 
synthesis but also affects downstream purification and separation processes. It was reported that 
impurities have a clearly negative influence on the nucleation and growth-rate kinetics of the 
crystallization of ampicillin (Shaohua Feng, 2006), which has a structure similar to that of amoxicillin. 
Besides these decomposition products, impurities derived directly from the amoxicillin synthesis, such 
as 4-hydroxy-L-phenylglycine that has similar structure and active groups, have to be considered and 
minimized to avoid this effect in the final purity  
 In view of the massive production of amoxicillin around the world and the marked influence of 
impurities on crystallization, cost-effective crystallization techniques to separate amoxicillin from 
degradation products are potentially of significant importance (Shaohua Feng, 2006; Kessels, 1993). 
 
 Another possibility could be a complementary step in the separation and/or purification 
process. Such step could an OSN system before crystallization, with the purpose of decreasing the 
concentration of impurities. In this study is the concentration of 4-hydroxy-L-phenylglycine that has to 
decrease in order to improving the feed stream for the crystallization process. As mention before, this 
membrane process works at ambient temperatures, is energy efficient and in theory is easy to scale-
up and operate with. Is mostly probable to be necessary the use of a membrane cascade system, 
derivative of the common problems of using an OSN process in API purifications already described. 
This can imply more equipment and controllability concerns, but may also enable an organic solvent 
recovery step, turning the all process more cost-efficient and environmental friendly. 
 
 Therefore, this dissertation will study the viability of this incorporation, focusing only in the 
elimination of a specific impurity, 4-hydroxy-L-phenylglycine, considering an initial solution purity of 
97.09% (initial solution concentrations used: 1g.L
-1
 for amoxicillin and 30 ppm for the impurity) and a 
final purity of at least 99.70% (represents an impurity concentration of 3ppm or less).  
 The initial solution concentrations established and the choice of the specific impurity to 
integrate in the solution are representative of an actual production challenge referenced by one of the 
study collaborators Massachusetts Institute of Technology (MIT). 
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3.1 Experimental 
 3.1.1 Model Mixture 
 All experimental nanofiltrations trials were performed using an aqueous solution containing the 
API Amoxicillin (MW=365.40 Da) in a concentration of 1g.L
-1
 and the impurity 4-hydroxy-L-
phenylglycine (sub-product of Amoxicillin enzymatic synthesis) (MW= 167.16 Da) in a concentration of 
0.03g.L
-1
 (30 ppm).  
 Two different volumes of the initial solution were used depending on the system: 50 mL when 
filtrating in a dead-end cell; and 200 mL when filtrating in an upside down membrane cell (membrane 
CSTR, m-CSTR). 
 
  3.1.1.1 Chemicals 
 Amoxicillin non try-hydrate powder (with 90.0% purity) and the 4-hydroxy-L-phenylglycine 
powder (with 99.0% purity) were purchased from Sigma-Aldrich. The Amoxicillin powder was stored at 
4ºC and the 4-hydroxy-L-phenylglycine powder was stored at room temperature. All chemicals were 
used as received without further purification. 
 
Table 3.1 - Amoxicillin and 4-hydroxy-l-phenylglycine relevant properties. (Data obtain from 
Sigma-Aldrich safety data sheets; Foulstone, 1982; O’Neil, 2001; VSDB and the chemical book 
via online) 
PROPERTIES AMOXICILLIN IMPURITY 
CAS Number 26787-78-0 32462-30-9 
Molecular formula C16H19N3O5S C8H9NO3 
Molecular weight 365.40 g.mol
-1
 167.16 g.mol
-1 
Appearance Powder /white crystalline solid White solid 
pH 4.4–4.9 (0.25% w/v solution) No literature data available 
Density (g.cm
-3
) 
No literature data available 
 
Experimental data: 6.126 
1 
Literature data: 1.396  
 
Experimental data: 0.928 
1
 
Melting point (ºC) 194 240 
Water solubility at 20
o
C  
(for tri-hydrate amoxicillin) 
3430 mg.L
-1 
Polar, Hydrophilic 
No literature data available 
Solubility in organic  
solvents at 20ºC 
(for tri-hydrate amoxicillin) 
Methanol: 7500 mg.L
-1
 
Ethanol: 3400 mg.L
-1
 
Soluble in: ether, dilute acids, 
alkalihydroxides solutions 
 
No literature data available 
Other solubility 
Lipid insoluble 
Low lipophilicity. 
 Water (likely at low pH) 
 Alcohol’s (methanol, 
ethanol) 
Stability/Reactivity Stable in gastric acid No literature data available 
Hazards identification 
Health issues - Reproduction / 
development effects 
Harmful by ingestion; irritant 
Material to avoid/ incompatible Oxidizing agents Strong oxidizing agents 
Storage Information 
Recommended storage 
temperature: 2 - 8 °C.  
Keep container tightly closed in a 
dry and well-ventilated place 
Keep container tightly closed 
in a dry and well-ventilated 
place. 
 
 
1 
Procedure followed: a quantity of powder was placed into a graduated cylinder (2 cm
3
) and weighed with 0.01% accuracy. The 
powder was gently compacted and flattened. The volume occupied by the powder in the cylinder was recorded. Dividing the 
mass of powder by the volume that occupies was possible to calculate de proximal density of the compound. 
CHAPTER III – MATERIALS AND METHODS 
FCT-UNL 
28 
 3.1.2 Amoxicillin characterization (solvent choice)  
  3.1.2.1 Solubility study 
 Solutions with 10 g.L
-1
 of amoxicillin were prepared in water, acetone, ethanol and methanol, 
separately. These solutions were maintained for 24 h with constant stirring and temperature set to 20 
ºC in a carrousel. Samples of 1 mL were taken, centrifuged, air dried at 20ºC, diluted in 1 mL of water 
and then analyzed by high pressure liquid chromatography (HPLC) (calibration curve presented in the 
appendix I). 
  3.1.2.2 Stability study 
 Solutions with 1g.L
-1
 of amoxicillin were prepared in water, acetone, ethanol and methanol, 
separately. These solutions were left to stir with the temperature set at 20ºC and were taken samples 
two times each day for two weeks. The first sample was taken after 15 min. of stirring to ensure the 
proper dilution of the powder in the solution. From the water and methanol mixtures, the samples were 
air dried at 20ºC and then diluted in 1 mL of water. The samples of the ethanol solution was first 
centrifuged, due to the presence of substantial quantity of non-dissolved powder in the bottom of the 
flask and then air dried and diluted in water. The procedure for the acetone solution was the same as 
for the ethanol solutions with an additional step of filtration, due to the appearance of powder floating 
in the solution after less than 24h. All the samples were then analyzed by HPLC (calibration curve 
presented in the appendix I). This experience was conducted twice using the same conditions. 
 3.1.2.3 Isoelectric point determination 
 A simple titration of both compounds (amoxicillin and 4-hydroxy-l-phenylglycine) was preceded 
at 20ºC. The 10 mL aqueous solutions of amoxicillin, with a concentration of 1.32 mmol.L
-1
, and 4-
hydroxy-l-phenylglycine, with a concentration of 1.43 mmol.L
-1
, were first neutralized with a 10 mmol.L
-
1
 acid chloride solution (acid purchased from VWR at 37%) and then titrated using a 49.65 mmol.L
-1 
sodium hydroxide solution (base purchased from VWR). These titrations were repeated twice being 
the results presented from the second trial. 
 
  3.1.2.3.1 Dissociation study 
 Ferreira F. C. A. in 2004
 
deducted an equation that permits to calculate the concentration of 
the neutral and ionic species for a given pH and therefore allows the study of the dissociation profiles 
of the different species in a solution. This author started by defining the general equilibrium of the 
chemical reaction of a stripping solution as, A   B  AB, being A the neutral organic, B the free ionic 
reagent (i.e hydroxide for organic acids and hydrogenium for organic bases) and AB the ionic organic 
product. He defines B concentration in the stirring solution, for an extraction of organic acid or basis, 
as 
C
B,S
 =  10
 pH
 
           Equation III.1 
in which Kw is the auto-ionization constant and pKw the correspondent pH. He also defines the total 
concentration of the organic in the stripping solution as the sum of the neutal organic concentration 
and the ionic organic product concentration: 
 
CB,S
T
 = CA,S  CAB,S. 
           Equation III.2 
 The equilibrium constant (K) can be directly related to the acid or base dissociation constant 
(Ka and Kb respectively), 
   =
CAB
CA . CB
= 
1
 b
 = 
 a
 w
  
           Equation III.3 
 Derived from Equations III.1, III.2 and III.3, the concentration of the neutral organic and the 
dissociated specie are given by, 
CA,S=
CB,S
T
1 CB,S. 
= 
CB,S
T
1 
 a
10
 pH
 
           Equation III.4 
CAB,S=1  CA,S 
           Equation III.5 
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 With these equations it is possible to study the dissociation profiles of each compound and 
compared them to see if the pH factor can favor the separation process. The base dissociation 
constant (Ka) is obtain from the p a’s determinated above for each specie ( a = 10
-pKa
). 
 
 3.1.3. Membranes 
 Polybenzimidazole (PBI) membranes were prepared for this work using the phase inversion 
technique. Were also used poly(ether ether ketone) (PEEK) and polyimide (PI) membranes prepared 
by colleagues in the laboratory as well as some purchased commercial membranes (DuraMem® 200, 
Thin Film Nanofiltration membrane and M130). 
 
Table 3.2 – Summary of the membrane tested in this work. 
Membrane 
Code 
Description MWCO (Da) 
PBI26 Polybenzimidazole, 26wt%, Uncrosslinked  600 
a
 
PBI22 Polybenzimidazole, 22wt%, Cross-linked with DBX for 24 hrs 350 
a
 
PBI20 Polybenzimidazole, 20wt%, Cross-linked with DBX for 24 hrs 430 
a
 
PBI17 Polybenzimidazole, 17wt%, Cross-linked with DBX for 24 hrs 550 
a
 
PI(1:4) Polyimide, 24 wt%, 1:4 (DMF:Dioxane), Uncrosslinked 395 
b
 
PI(1:3) Polyimide, 24 wt%, 1:3 (DMF:Dioxane), Uncrosslinked 395 
b
 
PI(1:2) Polyimide, 24 wt%, 1:2 (DMF:Dioxane), Uncrosslinked 395 
b
 
PEEK 
Poly(ether ether ketone), 12%, 1:3 (Sulphuric Acid: Methane 
Sulphonic Acid)  
300 
c
 
TFNF-DL Thin Film Nanofiltration membrane DL (GE Osmonics - Sterlitech) 150-300 
d 
M130 Commercial membrane (Evonik) 130 
e
 
DM200 DuraMem® 200 (Evonik) – P84® polyimide membrane 200 
e
 
a MWCO measured with a polystyrene/acetonitrile solution at 30 bar. 
b MWCO measured with a polystyrene /acetone solution at 15 bar. 
c MWCO measured with a polystyrene /DMF solution at 30 bar. 
d Obtained from Sterlitech Corporation website. 
e. Obtained from Evonik Industries website. 
  3.1.3.1 Polybenzimidazole membranes 
 
 Chemicals 
 Celazole® 26 wt%, a commercially available 26% dope solution of PBI in NN 
dimethylacetamide (DMAc), was purchased from PBI Performance products inc. DMAc and 
acetonitrile (MeCN) were purchased from VWR. Dibromobutane (DBB), and dibroxylene (DBX), used 
for the crosslinking reaction, and isopropanol (IPA) were purchased from Sigma Aldrich. Polyethylene 
glycol (PEG 400) was purchased from Merck. 
 
 Membrane preparation 
 When required, Celazole® 26 wt% was diluted with DMAc to a different polymer concentration 
and stirred continuously (IKA RW 20 digital) at room temperature overnight in order to obtain 
homogeneous dope solutions. The viscosity of the dope solution was measured in a rotary viscometer 
(MV-2020 Rotary Viscometer Cannon instruments, S16 spindle). Membranes were cast using the 
prepared dope solutions on a bench top laboratory casting machine with adjustable knife set at 250 
μm. The polymer film was applied (Elcometer 4340 Automatic Film Applicator) on non-woven 
polypropylene (PP), material used for mechanical support. Following this, the membranes were 
immersed in deionised (DI) precipitation bath at room temperature for approximately 24 h. The 
obtained membranes were washed with IPA (at least three times) to remove residual solvent and 
water. To crosslink the polymer the membranes were immersed in a 3 wt% DBX in MeCN solution and 
the reaction was carried out at 80 °C for 24 h. After the crosslinking reaction the membranes were first 
washed with IPA (at least three times) to remove residual crosslinking agent and later on immersed in 
a PEG400/IPA (v/v) bath for 4 h to preserve the pore structure. Finally, the membrane was air dried at 
20ºC to remove excess solvent. 
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  3.1.3.2 Membrane performance 
 Flux, J, and rejection, Ri, were used to evaluate the membrane performance. The flux was 
obtained by measuring the volume permeated, Vp, per unit area, A, per time unit, t, using the following 
equation, 
 = 
VP
A.t
 
           Equation III.6 
 
 The rejection of species, i, was calculated from its concentrations in the permeate, CP, i, and 
retentate, CR,i, using the following equation, 
Ri= (1  
CP,i
CR,i
)  100 
           Equation III.7 
 3.1.4 Experimental set-ups 
  3.1.4.1 Dead-end measurements 
 Membrane cell  
 Membrane screening tests were performed using a system like the one illustrated in Figure 
3.1. The dead-end cell, made of stainless steel, have a liquid capacity of 100 mL, and hold circular flat 
sheet membranes with an effective area of 19 cm
2
. These cells contain a magnetic stirrer in the 
feed/retentate chamber.  
 
 Membrane system 
 In all experiments the membrane active layer was placed against the feed solutions and forced 
through the membrane by an applied pressure (10, 20 and 30 bar) using nitrogen. The test ends when 
50% of the feed volume has been collected. 
 Prior to any diafiltrations the system was washed with water to wash away membrane 
preservatives and any remaining impurities from the previous filtrations. Samples from feed, retentate 
and permeate were taken in the beginning and in the end of each experiment. Samples were analyzed 
by high pressure liquid chromatography (HPLC) (calibration curve presented in the appendix I).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1 - Schematic of experimental pressure cell used for membrane screening. (Adapted 
from Scarpello and Livingston, 2002). 
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  3.1.4.2 m-CSTR upside down measurements 
 Membrane cell 
 The continuous system used in this work was set up using a membrane cell like the one 
schematized in Figure 3.2. The custom made cell (m-CSTR), made of stainless steel, have a liquid 
capacity of 92 mL, and hold circular flat sheet membranes with an effective area of 51 cm
2
. These 
cells operate in a bottom-to-top permeation mode, and contain a magnetic stirrer in the feed/retentate 
chamber (see Figure 3.2-A). Six ports surround the bottom section of the cells (see Figure 3.2-B). 
These were used as inlet (feed) and outlet (retentate and permeate) ports and to connect a pressure 
gauge for pressure monitoring and a temperature controller EKT Hein-Con (Heidolph). The retentate 
port was also connected to a pressure relief valve that allowed to control the pressure within the 
system. A safety pressure relief valve was also connected to one of the ports. All the ports not in use 
were maintained tapped.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2 – Layout of the membrane separator cell (m-CSTR). Legend: 1 – Inlet/outlet ports; 2 – 
Feed/retentate chamber; 3 – Inner o-ring; 4 – Membrane; 5 –Sintered plate; 6 – Outer o-ring; 7 – 
Cover. (Adapted from Peeva and Livingston, 2013). 
 
 Single membrane system 
 Single membrane purifications were performed using a system like the one illustrated in Figure 
3.3. This system consists of a feed tank and a single membrane cell. It operates in continuous or 
constant volume diafiltration mode: fresh solvent is added to the feed tank at the same rate as 
permeate comes out the membrane cell, so the system volume is always constant. Both feed tank and 
membrane cell are stirred using magnetic stirrers (500 rpm) to maintain homogeneity along the system 
and avoid osmotic pressure build up and concentration polarization effects in the membrane unit. 
Circulation is provided by a Gilson 307 HPLC pump able to provide feed flow rates up to 50 mL.min
-1
. 
To have control over the trans-membrane pressure within a certain range, the pump flow rate must be 
higher than the permeate flow rate at the maximum pressure of the chosen range.  
 
 The feed tank volume was 200 mL, and the volume of the cell plus the associated tubing was 
approximately 100 mL. All membranes were first washed with at least 1 L of pure solvent at the set 
pressure (20 or 30 bar) to remove all the conditioning agents and to achieve a steady-state flux. After 
draining the solvent from the cell, the filtration, using the model solution (1g.L
-1
 of the API and 30 ppm 
of the impurity in water), was performed for five hours. Permeate and retentate were recirculated back 
into the feed tank, not requiring the addition of pure solvent to the system. During experiments, 
samples were taken from feed, retentate and permeate at each hour. Samples were analyzed by 
HPLC (calibration curve presented in the appendix I). Before each new diafiltration the system was 
always washed with pure solvent to wash away membrane preservatives and any remaining impurities 
from the previous filtrations. 
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Figure 3.3 - Process diagram of the single membrane system (PI: Pressure gauge; TI: 
Temperature indicator). 
 
   3.1.4.2.1 Precipitated powder analysis 
 
 The powder was collected from the edge of the membrane and the inner o-rings, where 
concentrated, in the end of the complete diafiltration trial to a sample vessel. Formerly was dried in a 
vacuum system for 3 h at 22ºC and weighted. An aqueous solution of 1g.L
-1
 was prepared and a 1 mL 
sample was taken and analyzed by HPLC (calibration curve presented in the appendix I). 
 
   3.1.4.2.2 Mass transfer coefficient of amoxicillin 
 
 Approximating our process to a flat plate membrane in a stirred vessel using water as the 
solvent was possible to define that, 
 
NSh =
k . dvessel
D
=0.0443 .NRe
0.785
.NSc
0.33
 
                     Equation III.8 
 
in which Nsh is the Sherwoods number, k’ the mass transfer coefficient (m.s
-1
), dvessel is the vessel 
diameter (0.00844 m) and D the diffusion coefficient (m
2
.s
-1
) (Perry´s, 1999). NRe and NSc are the 
Reynolds and Schmidts number, respectively, that are defined as, 
 
NRe=
w.  dstirrer
2
.  ρ
μ
 
                     Equation III.9 
 
NSc  
 μ
ρ.  D
 
                    Equation III.10 
 
in which w is the radial speed of the stir (rad.s
-1
) having that the stirring speed used was 500rpm , 
dstirrer the stirrer diameter (0.002 m), ρ and μ are the density (1000 kg.m
-3
) and viscosity (0.001 Pa.s) of 
the API, respectively, and were considered to be the same as the water due to the low solute 
concentration in solution. 
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Back Pressure Regulator
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 The diffusion coefficient of the amoxicillin in water could be calculated using the Wilke and 
Chang correlation (Perry´s, 1999), 
DAPI   H2O = 7.4E
 8
. 
 T. ( 
H2O 
.M H2O) 
1
2
μ
H2O 
. VAPI
0.6
 
                    Equation III.11 
 
in which T is the work temperature ( 295.15 K),  
H2O 
 the association parameter that defines the 
effective molecular weight of the water with respect to the diffusion process (2.6 for water), M H2O is 
the water molecular weight (0.01802 kg.mol
-1
), μ
H2O 
 the water viscosity (1 cP) and VAPI is the 
amoxicillin molal volume (cm
3
.mol
-1
) that was considered to be equal to 500 cm
3
.mol
-1
 based on the 
estimation by the atomic contributions of LeBas (La-Scalea, 2005). 
 
   3.1.4.2.3 Concentration polarization analysis 
 
 Peeva et al. (2004) studied the effect of concentration polarization on flux in OSN. In the 
presented work a model based on the copulation of the solution diffusion model for membrane 
transport and the concentration polarization model for liquid film mass transfer, was proposed for a 
binary system to describe the membrane transport in a mass transfer limited system (Peeva and 
Livingston, 2004). The total volumetric flux (m
3
.m 
-2
.s
-1
) for the binary system is defined as, 
 
  =  solute.ʋsolute    solvent.ʋsolvent  
                    Equation III.12 
 
in which ʋ is the molar volume of the compound (m
3
.mol
-1
) and the fluxes of the solute and solvent are 
defined as, 
 solute
k solute
 = ln (
Csolute,FM  Csolute,P 
Csolute,   Csolute,P
) 
                    Equation III.13 
 solvent
k solvent
 = ln (
Csolvent,P   Csolvent,FM 
Csolvent,P   Csolvent, 
) 
                    Equation III.14 
 
 solute=Bsolute.(Csolute,FM    
 solute
 solute   solvent
 . exp (  
ʋsolute. P
RT
))   
                    Equation III.15 
 
 solvent=Bsolvent.(Csolvent,FM     
 solvent
 solute   solvent
 . exp (  
ʋsolvent. P
RT
)) 
                    Equation III.16 
 
Rsolute = 1   
 solute
 . Csolute, 
 
                    Equation III.17 
 
in which Csolute,FM  and Csolvent,FM are the concentrations in the feed side liquid phase at the membrane 
liquid interface (mol.m
-3
), Csolute,   and Csolvent,   are the concentrations in the feed side liquid phase in 
the bulk (mol.m
-3
), Csolute,P  and Csolvent,P  are the concentrations in the permeate side (mol.m
-3
),k’solute 
and k’solvent are the mass transfer coefficient (m.s
-1
),  solvent and  solvent are the permeabilities in the 
membrane phase (mol.m
-2
 s
-1
), P is the system pressure (Pa), R the ideal gas constant (8.3145 
m
3
.Pa.K
-1
.mol
-1
), T the system temperature (K) and Rsolute the solute rejection. Equations III.13 and 
III.14 describe the diffusion in the liquid film adjacent to the membrane, while Equations III.15 to III.16 
describe membrane transport and Equation III.17 defines the rejection.  
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 3.1.5 Analytical Methods 
 
 High Pressure Liquid Chromatography (HPLC) 
 
 All samples were analyzed by Agilent 1100 Series HPLC system coupled to an UV detector at 
280 nm and with an ACE C18 RP column (normal phase column). The pump flow-rate was set at 1 
mL.min
-1
, the injection volume was 30 μL, the column temperature was 30ºC, and an ACE C18 RP 
column was fitted. A mobile phase comprising of 5% MeOH (solvent A) and 95% 0.1 M ammonium 
acetate aqueous solution (solvent B) was used for 10 minutes. Calibration curves were obtained for 
each compound from the model mixture using the UV signal. 
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3.2 Process modelling 
 
 In order to understand and predict the separation behavior, using the membrane screening 
data, a simulation was performed for a semi-batch and continuous system using different 
configurations. 
 A simple modulation was performed following the assumptions below: 
 The system operates at constant volume. 
 The permeability and rejections are constant with time. 
 The solute concentration in the solution does not have a considerable influence on rejection. 
 Membranes in each stage have the same characteristics of rejection and permeability. 
 
 
 Parameters such as yield and purity were defined as, 
 
API Purity (%)=
Concentration of API
Concentration of API   Concentration of impurity
 x 100 
                    Equation III.18 
 
 ield of specie i (%)=
Final concentration of specie i
Initial concentration of specie i
  x 100 
                    Equation III.19 
 
  3.2.1 Semi-Batch mode 
 
One stage cascade system 
 
The single-stage diafiltration system, as shown in Figure 3.3, can be modeled by writing a 
mass balance around the system. Assuming that the system operates at a constant volume and it is 
perfectly mixed, 
 
V
dCR,i
dt
=   F. CP,i  =  V. A. CP,ii 
                    Equation III.20 
 
where V (L) is the entire system volume, F is the permeate flow-rate (L.h
-1
), Jv (L.m
-2
.h
-1
) is the 
membrane flux, A (m
2
) is the membrane area, and CR,i and CP,i (g.L
-1
) are the concentrations of specie 
i in the retentate and permeate, respectively. 
 
 Substituting Equation III.7 in Equation III.20,  
 
dCR,i
dt
= (
1
V
) .   V.  A. CR,i .(1   Ri)  
                    Equation III.21 
 
 
 This equation can be solved either numerically or analytically. When integrated analytically 
with appropriate boundary conditions, the following equation is obtained: 
 
CR,i
CR,i  
=exp [   
 V.  A. t
V
 .  (1   Ri)] =exp  [  vols. (1   Ri) ] 
                    Equation III.22 
 
where vols represent the total volume of permeate collected relative to the initial system volume. This 
useful time-like dimensionless parameter allows different diafiltration systems to be compared. 
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Two stage cascade system 
 
 In this two-stage configuration an assumption is made that the retentate streams from each 
stage are recycled back to the feed tank and can be solved numerically with MATLAB
® 
using ODE45 
function.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4 - Scheme of the two-stage cascade with the main equipment and streams 
highlighted. Legend: Feedcell – Feed flow-rate to the first stage; FR1 – Retentate flow-rate from 
stage 1; FP1 – Permeate flow-rate from stage 1; FP2 – Permeate flow-rate from stage 2; FR2 – 
Retentate flow-rate from stage 2. 
 
 The membrane cascade can be modeled by doing a mass balance to the first and second 
stages of the system: 
 
dCR1,i
dt
= (
1
V1
)       FP1.CR1,i .(1   R1,i)   FR2.  CR2,i  
                    Equation III.23 
 
dCR2,i
dt
= (
1
V2
)     FP1.  CR1,i.(1   R1,i)   FP2.  CP2,i     FR2   CR2,i   
                    Equation III.24 
 
with CP2,i = CR2,i.(1-R2,i) and where V1 is the feed tank plus the first-stage volume, V2 is the second-
stage volume, and Fj (equal to Jv. A) represents the flow-rate, being j the correspondent stream as 
shown in Figure 3.4. 
 An important parameter, the recycle ratio (Rc), is defined as, 
 
RC= 
FR2
FP1
=
(B1.  ΔP1   B2.  ΔP2)
B1.  ΔP1
 
                    Equation III.25 
 
where ΔP1 and ΔP2 (bar) represent the trans-membrane pressure (TMP) through the first and second 
stages, respectively, and B1 and B2 represent the permeability (L.m
-2
.hr
-1
.bar
-1
) of the first and second 
stage membranes, respectively. 
 
 The recycle ratio, RC, is an independent variable under control because the flow rate through 
the first and second membranes i.e, the permeate can be controlled using the back-pressure valve at 
the retentate side of the second stage. Notably, the effect of RC on the final yield and purity is 
significant and is discussed in the results section. 
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 3.2.2 Continuous mode 
 3.2.2.1 Configuration I 
 
 Two stage cascade system 
 
 In this two-stage continuous configuration an assumption is made that the retentate streams 
from each stage are recycled back to the feed tank and can be solved numerically with MATLAB
® 
using ODE45 function.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.5 - Scheme of the continuous two-stage cascade with the main equipment and 
streams highlighted. Legend: Feedin – Feed flow-rate in (to be purified); Feedout – Feed flow-rate 
out (purified); Feedcell – Feed flow-rate to the first stage; FR1 – Retentate flow-rate from stage 1; 
FP1 – Permeate flow-rate from stage 1; FP2 – Permeate flow-rate from stage 2; FR2 – Retentate 
flow-rate from stage 2. 
 
 The membrane cascade can be modeled by doing a mass balance to the first and second 
stages of the system: 
 
dCR1,i
dt
= (
1
V1
)    Feedin. Ci,0   FP1.CR1,i .(1   R1,i)  FR2   CR2,i   Feedout. Cout,i  
                    Equation III.26 
 
dCR2,i
dt
= (
1
V2
) .   FP1.  CR1,i (1   R1,i)   FP2.  CP2,i   FR2.  CR2,i  
                    Equation III.27 
 
with CP2,i = CR2,i.(1-R2,i) and where V1 is the feed tank plus the first-stage volume, V2 is the second-
stage volume, and Fj (equal to Jv. A) represents the flow-rate, being j the correspondent stream as 
shown in Figure 3.5. 
 
 The results from the equations above can be verified using the mass balance to the feed tank 
and a global mass balance: 
 
Mass balance to the feed tank:   
Feedin. Ci,0    FR1.  CR1,i   FR2.  CR2,i = Feedout. Cout   FFeedcell. CFeedcell,i  
 
                    Equation III.28 
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Global mass balance:    
Feedin. Ci,0= Feedout. Cout   FP2. CR2,i.(1   R2,i) 
                    Equation III.29 
 
 The recycle ratio (Rc) is defined as mentioned before, Equation III.25, and another important 
parameter, the feed utilization (FU), is defined as, 
F =
Feedin
Feedout
 
                    Equation III.30 
 
 Is a parameter that indicates how much of the feed in is going out as purified stream, i.e. it 
shows the volume reduction in the cascade system. 
 
  3.2.2.2 Configuration II 
  
 Two stage cascade system 
 
 This configuration is similar to the previous one but assumes that the retentate stream from 
the first stage and the permeate stream from the second stage are recycled back to the feed tank. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.6 - Scheme of the continuous two-stage cascade with the main equipment and 
streams highlighted. Legend: Feedin – Feed flow-rate in (to be purified); Feedout – Feed flow-rate 
out (purified); Feedcell – Feed flow-rate to the first stage; FR1 – Retentate flow-rate from stage 1; 
FP1 – Permeate flow-rate from stage 1; FP2 – Permeate flow-rate from stage 2; FR2 – Retentate 
flow-rate from stage 2. 
 
 As mentioned before, the membrane cascade can be modeled by performing a mass balance 
on stage 1 and 2 and solved numerically with MATLAB
® 
using ODE45 function. 
 
dCR1,i
dt
= (
1
V1
)    Feedin. Ci,0   FP1.CR1,i .(1   R1,i)   FP2.  CR2,i.(1   R2,i)   Feedout. Cout,i  
                    Equation III.31 
 
dCR2,i
dt
= (
1
V2
)     FP1.  CR1,i. (1   R1,i)   FP2.  CR2,i.(1   R2,i)   FR2.  CR2,i   
                    Equation III.32 
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where V1 is the feed tank plus the first-stage volume, V2 is the second-stage volume, and Fj, 
represents the flow-rate, being j the correspondent stream as shown in Figure 3.6. 
 
 The results from the equations above referred can be verified using the mass balance to the 
feed tank and a global mass balance: 
 
Mass balance to the feed tank:  
Feedin. Ci,0    FR1.  CR1,i    FP2.  CR2,i.(1   R2,i)= Feedout. Cout   FFeedcell. CFeedcell,i 
  
                    Equation III.33 
Global mass balance:  
Feedin. Ci,0= Feedout. Cout  FR2. CR2,i 
                    Equation III.34 
 
 The feed utilization is defined as before, Equation III.30, and the recycle ratio (Rc), is defined 
as, 
RC = 
FP2
FP1
=
 B2.  ΔP2
B1.  ΔP1
 
                    Equation III.35 
 
 Three stage cascade in steady state 
 
 A three stage cascade was also studied using the configuration in Figure 3.7.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.7 - Scheme of the continuous two-stage cascade with the main equipment and 
streams highlighted. Legend: Feedin – Feed flow-rate in (to be purified); Feedout – Feed flow-rate 
out (purified); Feedcell – Feed flow-rate to the first stage; FR1 – Retentate flow-rate from stage 1; 
FP1 – Permeate flow-rate from stage 1; FP2 – Permeate flow-rate from stage 2; FR2 – Retentate 
flow-rate from stage 2; FP3 – Permeate flow-rate from stage 3; FR3 – Retentate flow-rate from 
stage 3 
 Mass balances for each stage were developed to modulate this system.  
 
dCR1,i
dt
= (
1
V1
)    Feedin. Ci,0   FP1.CR1,i .(1   R1,i)   FR2.  CR2,i    FP3.CP3,i   Feedout. Cout,i  
                    Equation III.36 
dCR2,i
dt
= (
1
V2
)    FP1.  CR1,i .(1   R1,i)   FP2.  CR2,i.(1   R2,i)   FR2.  CR2,i   
                    Equation III.37 
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dCR3,i
dt
= (
1
V3
)     FP2.  CR2,i(1 R2,i)     FP3.CP3,i   FR3.  CR3,i  
                   Equation III.38 
 
with CP3,i = CR3,i.(1-R3,i) and where V1 is the feed tank plus the first-stage volume, V2 is the second-
stage volume, V3 is the third-stage volume, and Fj, represents the flow-rate, being j the correspondent 
stream as shown in Figure 3.7. 
 
 Considering steady state, the concentration profiles can be obtained analytically. Since 
CP1,i = CR1,i.(1-R1,i)= CFeedcell,i.(1-R1,i) and the Feedcell stream concentration will reach the same 
value as Feedout concentration when reaching steady state, CP1,i= Cout,i .(1-R1,i) and CR1,i =Cout,i  . 
 
Cout,i=(
Feedin. Ci,0   FP3.CR3,i (1   R3,i)   FR2.  CR2,i 
Feedout   FP1(1 R1,i)
) 
                    Equation III.39 
 
CR2,i= (
(Feedin. Ci,0   FP3.CR3,i(1   R3,i) ) . FP1. ( 1 R1,i )
Feedout . FR2   Feedout . FP2(1   R2,i)   FP1
(1   R1,i) FP2(1   R2,i)
) 
                    Equation III.40 
 
CR3,i= (
Feedin. Ci,0    ∏ .FPj(1 Rj,i)
2
j=1
Feedout . (FR2 . FR3  FP3(1   R3,i) . FR2   FP2(1   R2,i) . FR3   ∏ .FPj(1   Rj,i)
3
j=2 )  ∏ .FPj(1   Rj,i) . FR3
2
j=1  
) 
 
                    Equation III.41 
 
 The results from the equations above can be verified using the mass balance to the feed tank 
and a global mass balance: 
 
Mass balance to the feed tank:  
Feedin. Ci,0    FR1.  CR1,i   FR2.  CR2,i   FP3.CP3,i= Feedout. Cout   FFeedcell. CFeedcell,i 
 
                    Equation III.42 
Global mass balance: 
Feedin. Ci,0= Feedout. Cout  FR3.  CR3,i 
                    Equation III.43 
 
 Feed utilization is once again defined as above, Equation III.30, and the recycle ratio (Rc), in 
this case, is defined separately for each stage: 
 
Second stage:  
 
RC = 
FP2
FP1
=
 B2.  ΔP2
B1.  ΔP1
 
                                 Equation III.44 
Third stage: 
 
RC = 
FP3
FP2
=
 B3.  ΔP3
B2.  ΔP2
 
                     Equation III.45 
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4.1 Solvent choice 
 To proceed with the desirable purification of the API amoxicillin from the impurity, 4-hydroxy-L-
phenylglycine, it was necessary to choose the solvent to be used in the nanofiltration process.  
 Taking into account the literature data, vide Table 3.1, and some experimental trials made 
previously in this group (vide Table 4.1) with numerous potential organic solvents commonly used in 
OSN, the range of ideal solvents to use in this process was reduced to four possible solvents: water, 
acetone, ethanol and methanol.  
 
Table 4.1 – Results summary of the solvents tested in the laboratory previously. 
Solvent Soluble at 1 g.L
-1
, 
at 20ºC 
Stable for 48 h 
at 20ºC 
Water   
Methanol  degradation 
Acetone   
DMF  degradation 
DCM  n.a.
 #
 
MeCN  n.a.
 #
 
EtOAc  n.a.
 #
 
THF  n.a.
 #
 
Toluene  n.a.
 #
 
#
n.a. = not available 
= yes; = no 
 
 The study of the solubility and stability of the compound of interest (amoxicillin) in these 
solvents was conducted in order to understand the behaviour of the compound and choose the more 
suitable solvent for the OSN process. 
 
 4.1.1 Amoxicillin solubility and stability study 
 
 Solutions of amoxicillin were prepared separately in water, acetone, ethanol and methanol and 
left stirring in a carousel for 24 h at approximately 20ºC. This experience was repeated once using the 
same conditions. The results from the HPLC analysis (calibration curve presented in the appendix I). 
of the samples taken are presented in Table 4.2. 
 
Table 4.2. - Comparison of the results obtained for the amoxicillin solubility. 
Solutions prepared with 10g.L
-1
 of amoxicillin in the different solvents. 
Solubility (g.L
-1
)  
at 20ºC 
Literature Data
 
(Table 3.1) 
Experimental Data 
(after 24 h) 
*
 
Water 3.43 2.82 ± 0.02 
Acetone not available 1.41 ± 0.02 
Ethanol 3.40 0.39 ± 0.02 
Methanol 7.50 3.69 ± 0.02 
*
 Average of two experiences performed and error values represent one standard 
deviation from the mean. 
 
 From Table 4.2 it is possible to verify that water was the solvent with closer results to the 
literature data; ethanol and methanol solubility values were much lower than the expected. One of the 
possible factors for the discrepancy of values is that the literature data obtained for the solubility are 
for the tri-hydrate amoxicillin compound and in this research work the non-hydrate amoxicillin was 
used. The API has a reasonable solubility in water, and therefore the presence of three molecules of 
water in the compound molecular structure can have a significant effect in the solubility of the 
molecule. Nevertheless, this factor alone could not explain the decreased to less than half of the 
solubility values for the ethanol and methanol. A possible reason will be described in the stability 
study. 
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 Solutions of amoxicillin were prepared separately in water, acetone, ethanol and methanol to 
study the stability of the API over time in the different solvents. Samples of all solutions were taken for 
over two weeks and analyzed. 
 
 
Figure 4.1 – UV signal, from the HPLC analysis, of the samples taken over time for each 
solution. Solutions prepared with 1g.L
-1
 of amoxicillin in the different solvents. 
 
 From Figure 4.1 it is perceptible the loss of the API over time in all mixtures. After 21 h it can 
be seen for all mixtures, with the exception of the water mixture, a decrease in 40% or more from the 
initial amoxicillin concentration. 
 It was expected that ethanol would dissolve the API almost as well as water giving the fact that 
they have similar solubilities (vide Table 4.2). In all experimental trials, the amoxicillin powder 
dissolved after 15 min. of stirring at 22 ºC with the exception of the trials using the ethanol mixture. 
However, it was impossible to dissolve the 1 g.L
-1
 of amoxicillin in ethanol which means that the 
solubility is below 1 g.L
-1
. Examining Figure 4.1 it was noticeable from the beginning of the experiment 
that the API signal from the ethanol mixture was always significantly lower when compared to the 
other solvents. This brings an uncertainty about the ethanol solubility value from the literature data and 
corroborates the experimental data obtained in the solubility study described above. In addition, it was 
also noticeable another peak after 117 h that was no longer visible after 141 h but could be related to 
the formation of a decomposition product. 
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Figure 4.2 - Concentration of amoxicillin over time in the different solvents. Solutions prepared 
with 1 g.L
-1
 of amoxicillin. These results represent an average of two experiments and the error 
bars are the standard deviation of the mean. 
 
 Analyzing the concentration profiles over time for each solvent (Figure 4.2), it was possible to 
realize that the decomposition of amoxicillin over time had the slowest decrease when compared with 
the other solvents. After a period of 200 h water had a decrease in concentration of less than 10% 
while the other solvents had a decrease higher than 80%. It can also be noticed that the API had a low 
concentration in ethanol since time 0 h., probably due to its low solubility (as mentioned before). 
 The API concentration in acetone and methanol had a very quick decrease in concentration in 
the first 25 h. For acetone it was visible to the naked eye, in less than 24 h, the appearance of a white 
powder in the solution; this could be due to decomposition or precipitation. The solution was filtered to 
maximize the sample collection but the powder, even in much smaller quantities, continued to appear. 
Comparing the concentration profiles between methanol and acetone, methanol had an accentuated 
decrease of the API concentration over time, but not as pronounced as in the acetone mixture. This 
fast decrease in concentration can be the explanation for the low solubility values of methanol 
obtained experimentally. Since the solubility samples were taken after 24 h, at that point the 
amoxicillin concentration had already decreased approximately to half of the initial value. 
 Considering both studies and the information collected, the solvent chosen was water given 
the fact it had reasonable solubility and the best stability when compared with the other solvents. Even 
using water as a solvent, decomposition occurred and the stability of amoxicillin could be a serious 
issue in the membrane purification step.  
 In previous studies, it was showed that the amoxicillin solubility and stability is highly 
dependent on temperature and pH (Shaohua Feng, 2006; Francesco Crea, 2012; Morton, 2001; 
Vahdat, 2007; Sabegh, 2012). Solubility increases and stability decreases rapidly with the increase of 
temperature. In terms of pH conditions, it is known that the solubility increases significantly with higher 
(>8) and lower pH (<2) being the API stable in acid conditions. Nevertheless, the behavior of the 
amoxicillin with pH is complex and the literature data available is not enough to fully understand the 
pH effect. Being one of the key parameters for the success of the OSN purification process titration 
curves of both compounds were analyzed and a dissociation study was performed. 
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4.2 Isoelectric point determination  
 For better understanding of the behavior of the compounds with the pH, titrations of both 
compounds (Amoxicillin and 4-hydroxy-L-phenylglycine) were conducted. The standard solutions were 
prepared based on the study developed by Francesco Crea et al. in 2012. 
 
A)            B) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
C)              D) 
 
   
 
 
 
 
 
 
 
 
 
Figure 4.3 – Isoelectric point determination: A) Titration curve of amoxicillin a T=20ºC. 
Experimental conditions: CAPI= 1.32 mmol.L
-1
; CNaOH= 49.65 mmol.L
-1
; Viniz. = 10 mL; B) Titration 
curve of 4-hydroxy-L-phenylglycine a T=20ºC. Experimental conditions: CAPI= 1.43 mmol.L
-1
; 
CNaOH= 49.65 mmol.L
-1
; Viniz. = 10 mL; C) Molecular structure and ionizable groups from 
amoxicillin; D) Molecular structure of 4-hydroxy-L-phenylglycine. 
 
 The titration data was analyzed using a derivation method of finite elements and it was 
possible to determinate the NaOH volumes used in the inflexion point and as well as the exact pKa 
(see appendix II for calculations). 
 Comparing the amoxicillin titration curve obtained with the literature data, two of the three 
inflexion points were obtained: one possibly corresponding to the amine group (pKa ~ 7.00) and a 
second one possibly from the phenol group (pKa ~ 9.50) (Francesco Crea, 2012; Morton, 2001). From 
the literature data and observing the API structure in Figure 4.3 (C), it was expected a third inflexion 
point corresponding to the carboxylic acid group (pKa ~ 3). One explanation for the non-appearance of 
this inflexion point could be related to the fact that the pKa of carboxylic acid group is at a value close 
to the initial pH of the titration curve which could explain its absence from the titration curve. 
 No literature data was found about the acting groups of the 4-hydroxy-L-phenylglycine 
compound. Nevertheless, amoxicillin molecule is very similar in terms of groups but the interaction 
with each other could be different. From the titration curve it was possible to identify a pKa of 6.20 for 
4-hydroxy-L-phenylglycine. 
 After obtaining the isoelectric points of each compound there was the possibility of separating 
them using the ionic interactions and properties. 
HO
OH
H NH2
O
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 Ferreira F. C. A. in 2004 deducted an equation that allows the calculation of the concentration 
of the neutral and ionic species for a given pH and therefore allows the study of the dissociation 
profiles of the different species in a solution. From Equations III.4 and III.5, described in sub-section 
3.1.2.3.1, it was possible to study the dissociation profiles of each compound and compared them to 
see if the pH factor can favor the separation process. 
 
 
 
Figure 4.4 - Dissociation profiles of the amoxicillin and 4-hydroxy-L-phenylglycine, considering 
100% molar percentage in the beginning (see appendix III for calculations). 
 
 In numerous studies it was observed that membranes in general have a tendency to have a 
higher rejection for dissociated species than non-dissociated species (Manttari Mika, 2006). 
Nevertheless, this tendency can easily change depending on the membrane characteristics, such as 
charge or cross-linking degree, or even the model mixture used. 
 In Figure 4.4, starting with an acidic pH of 2.0, both compounds are in completely neutral form 
(100% molar percentage). Approaching a pH of approximately 5.0, 25% of amoxicillin (50% of the first 
ionized group) and 50% of the impurity compound were dissociated. Reaching a pH around 9.0, the 
impurity is completely dissociated, but only the first ionized group of amoxicillin is completely 
dissociated.  
 Being a binary mixture of two very similar compounds with no exhaustive background in the 
membrane investigation technology, it would be of extreme interest to execute a more detailed study 
of their behavior with the change of pH and the effect in their separation results. Besides, diafiltrations 
trials should be performed for each compound separately and as a mixture (varying the pH conditions) 
to understand the possible interactions with the workable membrane (usage of a different membrane 
as control). 
 For this study, it was thought that the most promising condition to perform the diafiltrations 
trials would be to use a pH of approximately 9, since with this pH it can be obtain a higher difference, 
in terms of dissociation groups, between the two compounds. The acidic conditions (pH 2.00 and 5.00) 
were also investigated in terms of rejection for the separation process. 
 Varying the pH was thought to be a crucial parameter and could make the difference between 
a suitable or unsuitable separation process using OSN for this study case.  
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4.3 Membrane screening 
 In order to identify the most suitable membrane for this separation process different types of 
membranes were tested: PBI, PI, PEEK, TFNF-DL, M130 and Duramem®200 (membrane description 
in sub-section 3.1.3). The choice of the membranes was based on their molecular weight cut-off, 
performance and interaction with water and also previous studies conducted with the API amoxicillin 
and other similar compounds using membrane technology (Sterlitech Corporation and Evonik 
Industries via online; Valtcheva, 2012; Shahtalebi, 2011). 
 The membrane screening was conducted in two different set-ups: dead-end measurements 
and m-CSTR upside down measurements, as described in sub-section 3.1.4.  
 In both set-ups, parameters such pressure and solution pHs were studied in the different 
membranes. The pressures tested were 10, 20 and 30 bar and the solution pH tested were 2.0, 4.9 
(pH of the solution containing the two compounds) and 8.6. The temperature was kept constant at 
22ºC in all trials. 
 A solution containing 1g.L
-1
 of amoxicillin and 0.03 g.L
-1
 (30 ppm) of 4-hydroxy-L-phenylglycine 
(impurity) was used to conduct the experiments. This solution had an initial pH of approximately 4.8 (at 
22 ºC) and the solvent used was water (as concluded in the sub-section 4.1).  
 When evaluating a membrane performance the two most important parameters are rejection 
and permeability. Permeability is often considered a critical variable; however, a high permeability is 
not always necessary or even desirable. In fact, especially in the pharmaceutical industry, it is often 
more important to achieve a high yield and level of purity, because complete retention of a particular 
solute is the main objective. Since there is always a trade-off between permeability and rejection, one 
must select the membrane that match as close as possible the specific process requirements. As a 
rule of thumb, the rejection of the smaller compound should not exceed 80% for the process to be 
practical and feasible. All rejections presented in this chapter were obtained by Equation III.7 using the 
calibration curves presented in the appendix I. 
 
 4.3.1 Dead-end measurements 
 
 The set-up configuration used for these measurements is described in the sub-section 3.1.4.1 
As mentioned before, prior to any diafiltration, the system was washed with water to wash away 
membrane preservatives or any remaining impurities from the previous filtrations and also to 
conditioned the membrane. The total solution volume used for the filtration trials was 50 mL. The mass 
balance error for the solution concentration in all trials was of 9 ± 6% for the API and 10± 8% for the 
impurity. 
 The effect of operating pressure on solute rejection has been studied extensively by many 
authors (Bowen, 2002; Peeva and Livingston, 2004). In NF, solute rejection is usually observed to 
increase with rising pressure. Therefore, firstly the membranes were first screened by varying the 
system pressure (measurements at 10, 20 and 30 bar), maintaining temperature and pH conditions 
constant. 
 Knowing the molecular structures of the mixture compounds it is expected that the solutes 
rejections will be very similar. Therefore, and considering the analysis performed in section 4.2, 
experimental trials were performed by changing the pH of the solution (to a pH of 2.0, 4.8 and 8.6). 
These experiments were performed for the membranes selected in the initial trials: PBI22, PBI20, 
TFNF-DL and PI(1:4) membranes. 
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  4.3.1.1 Pressure effect 
 
 The results from the trials performed at 10 bar are presented in Table 4.3. 
  
Table 4.3 - Summary of the screening results conducted using water as solvent with a pressure 
of 10 bar and a temperature of 22ºC.  
Membrane 
a 
Rejection (%) Flux 
b
 
(L.m
-2
.h
-1
) API Impurity 
PBI26 
c
 - - - 
PBI22- A(1) 97.78 90.18 19.7 ± 2.1 
PBI22- A(2) 98.83 95.25 11 ± 1 
PBI20- A(1) 96.85 90.16 11.9 ± 0.7 
PBI20- A(2) 88.12 73.96 15.7 ± 0.7 
PBI17- A(1) 44.8 25.99 43 ± 8 
PBI17- A(2) 19.2 11.04 53.8 ± 12.2 
PI(1:4)- A 67.12 47.4 5.9 ± 0.9 
PI(1:4)- B(1) 77.39 55.03 4.2 ± 0.3 
PI(1:3) 61.45 44.92 13.4 ± 1.7 
PI(1:2) 60.03 49.35 30.8 ± 0.8 
PEEK 
c
 - - - 
TFNF-DL- A 99.36 95.07 34.3 ± 1.5 
TFNF-DL- B 98.04 94.17 32.6 ± 2.1 
M130 63.01 52.96 32 ± 3 
DM200 59.64 52.08 31.9 ± 2.8 
a Letter indicates the membrane batch; number in parenthesis indicates the membrane coupon  
b Error values represent the standard deviation of the mean. 
c Membrane with negligible flux. 
 
 From the initial trials presented above, it can be seen that the PBI26 and PEEK membranes 
did not have any rejection or flux results and this was due to their very low flux. 
 It is also possible to see that PBI17 membrane had low rejections and high fluxes for both 
compounds, which could mean an inappropriate MWCO for the case study having all solutes been 
permeated through the membrane. 
 PI membranes had low fluxes and API rejections not high enough to achieve a satisfactory 
yield. 
 For the M130 and Duramem®200 membranes there was a trade-off between permeability and 
rejection. Although their flux was more than satisfactory to work with, their rejections were very low for 
the API (around 60%). 
 PBI22, PBI20 and TFNF-DL were the best membranes having high rejections for the API 
(close to 99%) and reasonable fluxes (around 12 L.m
-2
.h
-1
 for the PBI membranes and 34 L.m
-2
.h
-1
 for 
the TFNF-DL membranes). PBI20- A(2) had lower rejections values which could be related to a defect 
in the membrane surface. 
 Both PBI (PBI26 to PBI17) and PI (PI(1:4) to PI(1:2)) membranes showed consistency and the 
expected trend as the proportion of polymer in the dope decreased, the rejection of the membrane 
decreased and its permeability increased correspondingly. This trend towards tighter membranes with 
higher polymer fraction has been observed previously (See Toh, Ferreira and Livingston, 2007). 
 Evaluating these initial trials it can be concluded that the difference between the compounds 
rejections was very similar which will constitute the main limitation for the separation process. 
 The results from the trials performed at 20 bar are described in Table 4.4. 
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Table 4.4 - Summary of the screening results conducted using water as solvent with a pressure 
of 20 bar and a temperature of 22ºC. 
Membrane 
a
 
Rejection (%) Flux 
b
 
(L.m
-2
.h
-1
) API Impurity 
PBI26 
c
 - - - 
PBI22- A(1) 98.45 92.05 25 ± 1 
PBI22- A(2) 99.13 96.6 20.9 ± 0.5 
PBI20- A(1) 97.77 93.62 19.9 ± 0.5 
PBI20- A(2) 88.60 73.21 27.5 ± 1.4 
PBI17- A(1) 45.49 35.01 62.7 ± 6.7 
PBI17- A(2) 27.05 29.05 79 ±16 
PI(1:4)- A 91.02 79.51 10.7 ± 0.6 
PI(1:4)- B(1) 93.08 78.94 7.9 ± 1.9 
PI(1:3) 72.74 49.05 22.8 ± 0.5 
PI(1:2) 63.95 48.57 51 ± 2 
PEEK 
c
 - - - 
TFNF-DL- A  96.88 92.91 63 ± 9 
TFNF-DL- B 98.74 95.11 59 ± 3 
M130 74.06 60.33 45 ± 1 
DM200 58.57 52.98 46.1 ± 0.5 
a Letter indicates the membrane batch; number in parenthesis indicates the membrane coupon. 
b Error values represent the standard deviation of the mean.  
c Membrane with very low flux. 
 
 
 As seen for 10 bar pressure, PBI26 and PEEK membranes continued to have insufficient flux 
to obtain any results. 
 As expected, almost in all membranes the flux and rejection values increased with pressure. 
Even so, for the PBI17, M130 and DM200 membranes this increase was not enough to make them 
one of the possible membranes to be used. 
 On the contrary, the PI(1:4) membrane showed 90% rejection for the API, which was not 
enough for a suitable purification process but could be an option to considerer if the rejection 
increased again when using a higher pressure . 
 The best results in terms of rejection were obtained for the PBI22 and TFNF-DL membranes, 
which presented even higher fluxes when comparing with the ones obtained at 10 bar. The membrane 
TFNF-DL- A did not follow this trend but it could be related to the damage of the membrane surface 
during prior to its insertion in the cell. 
 The increasing of the API rejection with pressure was a positive achievement but the rejection 
of impurity increased proportionally, i.e., the difference of rejection remained constant. 
 The results from the trials performed at 30 bar are described in Table 4.5. 
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Table 4.5 - Summary of the screening results conducted using water as solvent with a pressure 
of 30 bar and a temperature of 22ºC. 
Membrane 
a
 
Rejection (%) Flux 
b 
(L.m
-2
.h
-1
) API Impurity 
PBI26 
c
 - - - 
PBI22- A(1) 98.60 94.05 31 ± 5 
PBI22- A(2) 99.22 96.88 28.1 ± 0.8 
PBI20- A(1) 98.68 95.63 25 ± 3 
PBI20- A(2) 91.40 78.21 31 ± 4 
PBI17- A(1) 26.89 20.2 163.8 ± 28.5 
PBI17- A(2) 25.68 29.24 106.3 ± 4.8 
PI(1:4)- A 96.68 94.81 13.2 ± 1.7 
PI(1:4)- B(1) 94.93 84.6 11.6 ± 0.8 
PI(1:3) 78.76 62.19 32 ± 3 
PI(1:2) 75.61 64.16 51.5 ± 6.1 
PEEK 
c
 43.3 41 0.27 
f
 
TFNF-DL- A 97.68 92.29 85 ± 10 
TFNF-DL- B 99.02 95.50 81 ± 15 
M130 79.03 68.12 60 ± 2 
DM200 66.39 59.62 72.6 ± 7.4 
a Letter indicates the membrane batch; number in parenthesis indicates the membrane coupon  
b Error values represent the standard deviation of the mean.  
c Membrane with very low flux. 
f Only one value available 
 
 Using a pressure of 30 bar it was possible to measure the flux for PEEK membrane, but as 
can be seen this membrane had low rejections and a flux that was not workable from a practical point 
of view.  
 PBI26 membrane did not show any flux and for that reason it was discarded. 
 PBI17,PI(1:3), PI(1:2), M130 and DM200 membranes demonstrated in all trials to have poor 
rejections for both compounds so they were also put aside as suitable membranes for this separation 
case. 
 By increasing the applied pressure, PI(1:4) membrane gained interest since its API rejection 
increased from approximately 70%, at 10 bar, to approximately 96%, at 30 bar. Membrane PI(1:4)-
B(1) presented the highest difference between solute rejections, 10 p.p., considering all experimental 
trials. 
 Membranes that showed better performance and could be applied to this process were PBI20, 
PBI22 and TFNF-DL. TFNF-DL had higher flux compared with PBI membranes but the rejections are 
similar.  
 Ideally an API rejection of 100 % and a low or medium rejection for the impurity would be 
preferable. Similarly to many other studies of NF, as the membrane gets tighter, the rejection of the 
smaller compound increased in parallel with that of the larger one. Thus, if the membrane is tight 
enough for the rejection of the larger species to approach 100%, then the rejection of the smaller one 
would also become higher with reduced permeability. This parallel increase in rejection is also 
observed when increasing the pressure, but it reaches a point that the API rejection is not significantly 
affected by the increase of pressure and only the impurity rejection continues to increase, resulting in 
an even lower difference between their rejections. This can be seen in Table 4.5 for PBI22 and PBI20 
membranes. In this particular case it would be more logical to use lower pressures (20 bar for 
example) since the API rejection was practically the same but the difference of solute rejections was 
higher. 
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 In summary, it was possible to have a considerable high rejection of API (99%), using the PBI 
and TFNF-DL membranes, but with a high impurity rejection as well (95%). A maximum of 10 p.p. 
difference between solutes rejections was obtained using the PI(1:4) membrane, but the API rejection 
was 5 p.p. lower when compared with the other suitable membranes (94%). 
 PBI22, PBI20, TFNF-DL and PI(1:4) membranes were selected to proceed with the 
optimization study by changing the pH of the model mixture. 
 
 4.3.1.2 Separation optimization based on solution pH effect 
 
 The experiments using PBI membranes were not performed at 30 bar because as it was seen 
the difference between solutes rejections was higher at lower pressures. In addition, PBI membranes 
are sensitive at higher pressures because of compaction (Valtcheva, 2012). 
  
Table 4.6 - Summary of the screening results conducted using water as solvent at 22ºC. 
Membrane 
a P 
(bar) 
Rejection (%) Flux 
b 
(L.m
-2
.h
-1
)
 
Solution pH 
(at 20ºC) API Impurity 
PBI22- B 10 99.08 95.61 13.6 ± 1.6 5.1 
20 99.38 97.24 22.1 ± 0.8 - 
20 99.11 95.58 20.1 ± 0.6 2.0 
c
 
20 98.05 88.18 20.5 ± 1.9 8.7 
d
 
       
PBI20- B 10 94.22 85.97 16.3 ± 1.6 4.8 
 20 95.43 90.81 24.0 ± 1.8 - 
 20 95.20 90.01 22.31 ± 1.5 2.0
 c
 
 20 97.75 86.63 12.99 ± 0.68 8.6
 d
 
       
PI(1:4)- B(2) 10 70.26 49.26 5.3 ± 0.4 5.1 
20 73.12 61.06 10.2 ± 0.7 - 
30 81.27 73.02 13.5  ± 0.8 - 
30 82.95 76.67 13.5 ± 0.6 2.0
 c
 
30 86.48 71.93 13.3 ± 0.6 8.7
 d
 
       
TFNF-DL- B 10 98.61 94.17 30.6 ± 3.1 4.9 
20 99.04 95.11 51 ± 13 - 
30 99.02 94.3 77 ± 13 - 
30 98.83 94.18 101.6 ± 20.3 2.3
 c
 
30 98.92 89.65 89.3 ± 10.8 8.7
 d
 
a Letter indicates the membrane batch; number in parenthesis indicates the membrane coupon  
b Error values represent the standard deviation of the mean.  
c Change of pH with HCl (0.8M) with a dilution effect of .20% for both compounds  
d Change of pH with NaOH (0.1M) with a dilution effect of .20% for both compounds 
 
 Analyzing all the results obtained, a clear effect in the rejection of the compounds was 
observed when changing the solution pH to 8.7. A decrease in the rejection of the impurity occurred 
due to pH change which increased the difference in rejection of both solutes (positive effect). 
 Rejections and fluxes obtained in all trials before the change of pH were consistent with the 
previous results, with the exception of the PI(1:4) membrane, probably due to a defect in the 
membrane surface.  
 For the mixtures at pH 4.9 and 8.6 but at the same pressure one can verify that the difference 
in rejection between the solutes was the double when changing the pH from 4.9 to 8.6. The maximum 
different obtained between the compounds rejections was of approximately 10 p.p. in all membranes 
except for the PI(1:4) membrane. 
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 When changing the pH to 8.6 it was noticeable a decrease in flux when using PBI membranes, 
which was expected from previous studies (Valtcheva, 2012). The PBI20- B had a more significant 
decrease in flux when changing the solution pH to 8.6. This decrease in flux could be due to 
compaction, fouling effects, like membrane adsorption or pore blocking. 
 For the TFNF-DL membranes the effect was the opposite, the flux increased with the change 
of pH. If the membrane is charged, as it happens with PBI membranes, by changing the pH of the 
solution interactions between the compound and the membrane could have occurred which could 
explain the change in performance. Other possibility could be an eventual increase in the pore 
swelling and consequently a higher permeability (Manttari Mika, 2006). 
 From the results it was clear that by changing the pH to 8.6 the separation process was 
optimized. In summary, it was possible to have a high rejection of API (98-99%) using the PBI22 and 
TFNF-DL membranes and a difference of 10 p.p. between the rejection of API and impurity, which was 
not possible by maintaining the pH constant. 
 Considering all the results from the membrane screening using dead-end measurements it 
was possible to select the most suitable membranes and conditions for the following filtrations studies: 
PBI22 membrane using a pressure of 20 bar and TFNF-DL using a pressure of 30 bar, both using 
optimized pH conditions. 
 
 4.3.2 m-CSTR upside down measurements 
 It is known that the dead-end filtration mode has a lot of fouling and concentration polarization 
problems as described in sub-section 1.2.3. A cross-flow mode is preferably used in diafiltrations 
being less susceptive to these problems and normally better rejections are obtained.  
 Therefore, a more exhaustive screening using a set-up with an m-CSTR upside down cell was 
performed for PBI22 and TFNF-DL. It is important to run diafiltrations tests in this mode to confirm the 
results obtained with the previous set-up and to see if there is any possibility to improvement. 
 The system proposed for this screening is illustrated in Figure 4.5 and described in detail in 
the sub-section 3.1.4.2. The flow was supplied using only a single pump and the pressure was 
regulated using a backpressure regulator in the downstream. The retentate from the membrane cell 
was recycled and each component of the system was stirred vigorously to guarantee that the 
compounds are well mixed and minimize any adverse concentration polarization effects inside the 
membrane cells. Furthermore, this system operates in a self-regulating manner, so no external control 
was required once the process starts. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.5 - Process diagram of the single membrane system (PI: Pressure gauge; TI: 
Temperature indicator). 
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 As mentioned before, prior to any diafiltration, the system was washed with water to achieve 
steady state flux and also to wash away membrane preservatives and any remaining impurities from 
the previous filtrations The total solution volume used for the filtration trials was 200 mL. The mass 
balance error for the solution concentration in all trials was of 16 ± 14% for the API and 12 ± 19% for 
the impurity. 
 Firstly, diafiltrations without changing the solution pH were conducted for each trial to condition 
the membrane and to have comparative rejection values. The initial solution was always drained from 
the cell to conduct the pH exchange and the membrane clean with water for more than 1h before 
proceeding with the filtration with a basic pH. 
 
   4.3.2.1 PBI22 screening results 
 
Table 4.7 - Summary of the screening results conducted using water as solvent at 20 bar at 
22ºC. Pure solvent average flux is 52.5 ± 2.5 L.m
-2
.h
-1
. 
Membrane
 a
 
Filtration time 
(h) 
 
Rejection (%) Flux 
b
 
(L.m
-2
.h
-1
) 
 
Solution pH 
(measured at 20ºC) 
 API Impurity 
PBI22- C (1) 
 
 
 
0 - - - 5.1 
1 94.28 93.88 
31.4± 0.4 
(at 27ºC) 
4.3 
cleaned with 500 mL of water 
0 - - - 8.6 
c
 
1 98.83 95.29 26.5± 0.8 - 
4 98.60 95.92 - - 
5 98.87 96.19 26.79± 0.27 8.2 
PBI22- C (2) 
 
 
 
0 - - - 5.0 
1 93.17 88.98 24.26± 1.21 4.0 
cleaned with 500 mL of water 
0 - - - 8.6
 c
 
1 96.16 77.71 23.4± 0.7 - 
4 93.86 81.48 - - 
5 94.00 82.62 18.5± 0.3 7.9 
PBI22- D  
 
 
 
0 - - - 5.0 
1 96.23 89.17 25.21± 0.59 4.1 
cleaned with 500 mL of water 
0 - - - 8.7
 c
 
3 92.69 71.26 26.79± 0.58 
 
4 91.86 73.38 - - 
5 92.64 74.28 26.5± 0.7 8.0 
a Letter indicates the membrane batch; number in parenthesis indicates the membrane coupon  
b Error values represent one standard deviation of the mean.  
c Change of pH with NaOH (0.1M) with negligible dilution effect (2% for both compounds). 
 
 From Table 4.7 it can be seen that the permeate flux was, from the beginning, smaller than the 
pure solvent flux. This difference was already observed by many authors for different solute-solvent 
systems (Yang et al., 2001; Whu, Baltzis and Sirkar, 2000; Gibbins et al., 2002), and can have several 
causes, such as osmotic pressure, concentration polarization or hindered diffusion within the pores. 
Analyzing the fluxes at a normal pH and comparing with dead-end results (Table 4.5 and 4.6), it can 
be seen that all trials were consistent (see sub-section 4.3.1). Only the flux obtained for the PBI22- 
C(1) membrane was higher but this has to do with the high temperature of the measurement (27ºC). 
Temperature is one of the factors that influence the permeability flow since with its increase the pores 
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tend to be more flexible and the solvent viscosity tends to decrease, facilitating the permeability of the 
solution. 
 As seen in the dead-end measurements (Table 4.6), the PBI22 membrane permeate flux 
dropped from 22.1 ± 0.8 to 20.5 ± 1.9 L.m
-2
.h
-1
 when changing the pH to basic conditions (see sub-
section 4.3.1.2). The PBI22 – C(2) membrane was the only one with a drastic drop of flux along the 
diafiltration process when changing the pH to 8.6 (from 24.26 ± 1.21 to 18.5 ± 0.3 L.m
-2
.h
-1
). This could 
be attributed to membrane compaction. However, membrane compaction is normally accompanied by 
an increase in the rejection which was not observed. Thus, it was more likely that the flux continued to 
drop due to fouling effects, like membrane adsorption or pore blocking. At the end of the trial 
considerable quantities of white powder were observed close to the edges of the membrane and in the 
inner o-rings. This phenomenon could be the reason for the drastic drop in flux and will be discussed 
in sub-section 4.3.2.2.1. 
 Comparing both systems for PBI22 membranes it was observed a considerable difference 
between the rejections values obtained. With the use of a cross-flow mode system it was expected 
that the rejection of solutes would increase or maintain the same tendency of values observed before 
(in the range of 98-99% for the API; and for the impurity 94-96% with normal pH and 88-89% with 
basic pH). Observing Table 4.7, it can be seen that the rejections values for both compounds in the 
different pH conditions dropped in all membranes tested. 
 Considering the PBI22- C(1) membrane before the pH change, the API rejection was lower 
and the difference between solute rejection almost disappeared. When modifying the pH the API 
rejection increased to a coherent value having in consideration the previous results and it was 
practically constant over the diafiltration process. Nevertheless, a significant decrease of the impurity 
rejection was not observed as before, not having an improvement in the difference between solute 
rejections. 
 For the PBI22- C(2) membrane it was observed the same low rejection for API (93.17%) that 
increased after changing the pH to 8.6 (same trend as PBI22-C(1)). As expected from the dead-end 
measurements, the impurity rejection went down in 10 p.p. corroborating the positive effect of the pH 
in the separation.  
 In PBI22- D membrane, the initial rejection was satisfactory but when changing the pH, a 
significant drop in 5 p.p was observed. In the previous membrane (PBI22-C(2)), the impurity rejection 
went down , with a decrease of 20 p.p.. This higher decreased in the impurity rejection probably was 
due to the parallel decreased in the API rejection.  
 Previous studies using PBI membranes showed decreases in rejections during the diafiltration 
process due to interactions between the cross-linker present in the membrane and the filtration solvent 
(Valtcheva, 2012). A parallel project was being performed by co-workers at the Andrews Livingston 
Group, Piers Gaffney and Jeong Kim, with a similar problem using cross-linked PBI membranes. Their 
objective was to remove byproducts from a chain reaction using an OSN process. Unfortunately the 
byproducts rejections were being too high, even when using a suitable MWCO. They hypothesized 
that the anionic byproducts could be ion exchanging with the original bromide counter-ions within the 
PBI membrane from the cross-linking reaction. Therefore, they added a salt to the solution allowing 
the exchange of the byproduct ions associated with the ions in solution, being then capable to remove 
effectively the byproducts from the solution. 
 The cross-linker of the PBI membrane used in this work, as indicated in sub-section 3.1.3.1, 
was dibroxylene (DBX). Analyzing the pH measurements in all trials, it can be seen a decrease in the 
solution pH in all membranes after performing the diafiltrations trials. An interaction with the cross-
linker certainly would have this effect since the cross-linker is formed by bromide groups that are 
negatively charged. Since the mixture compounds seem to be sensitive to the pH conditions, as 
shown before, this variability of the pH could be the reason for the inconsistent performance in the 
different diafiltration trials. Nevertheless, depending on the cross-linking degree, the membrane can 
have more or less bromide groups, which could mean a higher or lower interaction with the module 
mixture. Combining this with the variability originated from the preparation steps, such as the dope 
solution and casting of the membrane, a significant effect in the membrane performance could be 
expected. 
 Understand and control this interaction phenomena is crucial for the use of this membranes in 
this specific separation process. Currently, PBI membranes are being considered as a solution for 
many problems in OSN processes such as basic and acidic conditions. 
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   4.3.2.2 TFNF-DL screening results 
 
Table 4.8 - Summary of the screening results conducted using water as solvent at 20 and 30 
bar at 22ºC. Pure solvent average flux is 160.7 ± 0.1 L.m
-2
.h
-1
 at 20bar and 225.0 ± 15.2 L.m
-2
.h
-1
 
at 30 bar. 
Membrane
 a
 
Filtration time 
(h) 
 
Rejection (%) Flux 
b
 
(L.m
-2
.h
-1
) 
 
Solution pH 
(measured at 20ºC) 
API Impurity 
TFNF-DL- C  
 
20 bar 
 
 
 
0 - - - 4.8 
1 92.08 84.48 25.2± 0.5 4.7 
cleaned with 500 mL of water 
0 - - - 8.7 
c
 
1 95.95 68.08 95± 6 - 
4 97.07 74.15 - - 
5 96.87 74.29 99± 4 8.6 
TFNF-DL- D 
 
 
30 bar 
 
 
0 - - - 4.7 
1 97.51 94.40 26.8± 0.8 4.7 
cleaned with 500 mL of water 
0 - - - 8.7
 c
 
1 97.89 84.57 68± 3 - 
4 98.90 85.89 - - 
5 98.93 86.20 68± 2 8.5 
TFNF-DL- E 
 
30 bar 
 
 
 
0 - - - 4.7 
1 97.23 93.01 26.25± 0.54 4.8 
cleaned with 500 mL of water 
0 - - - 8.7
 c
 
1 98.94 85.89 64± 3 
 
4 99.11 86.07 - - 
5 99.12 87.80 64.3± 0.0 8.6 
a Letter indicates the membrane batch; number in parenthesis indicates the membrane coupon  
b Error values represent the standard deviation of the mean.  
c Change of pH with NaOH (0.1M) with negligible dilution effect (2% for both compounds). 
 
 
 A trial using a pressure of 20 bar was performed to allow a latter comparison between the 
results from TFNF-DL and PBI22 membranes under the same conditions. 
 As observed with PBI22 membranes, the permeate flux was also, from the beginning, smaller 
than the pure solvent flux (vide Table 4.8). As explained before, osmotic pressure, concentration 
polarization or hindered diffusion within the pores can be the causes of this flux decrease. In addition, 
as seen in the dead-end measurements (vide Table 4.6), the permeate flux increased when changing 
the pH conditions to 8.7.  
 In the dead-end measurements, an API rejection of 99%, using a 30 bar pressure, was 
obtained and a difference between solute rejections of approximately 10 p.p. was observed when 
increasing the solution pH to 8.7. Comparing these results with the ones described in Table 4.8, it can 
be seen that they are reasonably consistent which proves the membrane reproducibility. 
 It is important to notice that in these trials the solution pH did not change during the 
diafiltration, as it happened with PBI22 membranes, which corroborates the justification given above to 
the inconsistent results obtained for the PBI trials. 
 In the previous trials, using the dead-end system, it was possible to obtain a flux around 80 
L.m
-2
h
-1
 in a standard pH (≈ 4.9) and a flux of 90 L.m
-2
h
-1
 using the module mixture with a basic pH 
(≈8.6), both at 30 bar. A significant decrease in the permeate flux was observed for the trials using 
standard pH (comparing dead-end with cross-flow) and for the trials using pH of 8.6 (comparing dead-
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end with cross-flow); this decrease was of 55% and 36%, respectively. At the end of the each 
membrane experimental trial, a considerable amount of white powder was observed close to the 
edges of the membrane sheet and in the inner o-rings, as observed with the PBI22- C(2) membrane in 
the previous sub-section 4.3.2.1. This powder precipitation could be related to the flux drop observed 
in some trials. Considering the quantities and the consistence of the powder observed, it was thought 
to be amoxicillin precipitation. Since this phenomenon was occurring with some frequency and in 
considerable amounts, analyzes of the powder were performed in order to verify what was causing 
this precipitation phenomena. 
 
   4.3.2.2.1 Precipitated powder analysis 
 At the end of each membrane trial, the precipitated powder was thoroughly collected from the 
edge of the membrane and the o-rings, dried and weighted (process description in sub-section 
3.1.4.2.1). An aqueous solution with a concentration of approximately 1 g.L
-1
 (in two of the three trials 
was used a lower concentration due to the poor quantities of powder available) was prepared and a 
sample collected for HPLC analysis (calibration curves are presented in appendice I).  
 In Figure 4.6 are shown the HPLC UV signals of the mixture compounds, amoxicillin and 4-
hydroxy-L-phenylglycine, in 1 g.L
-1
 aqueous solution, for comparison purposes. 
 
A)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.6 – HPLC UV signal from the mixture compounds in 1 g.L
-1
 aqueous solution: A) 
amoxicillin (90.0% pure); B) 4-hidroxy-L-phenylglycine (99.0% pure). The red points indicate the 
different peak areas and the label values the retention times of those peaks. 
 
 Figure 4.6 A) shows the amoxicillin peak after 6.72 minutes with a UV signal of approximately 
50 units. It was possible to identify four extra peaks, in which only three have a quantifiable area. 
Since the purchased powder was only 90.0% pure, these other peaks most likely correspond to those 
impurities present in the original powder. Observing the Figure 4.6 B) it can be seen a clear peak of 
the impurity of study that appears after 3.30 minutes. 
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 Having the signal profiles of the original compounds, a comparison with the precipitated 
powder collected from the diafiltration using the TFNF-DL membrane can be made. 
 In Figure 4.7 the HPLC UV signals from the precipitated powder collected in the screening 
trials for each TFNF-DL membrane are shown. 
 
A)             B)  
C) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.7 - HPLC UV signal results from the powder analysis. A) powder from TFNF-DL- C 
membrane trial at 0.7 g.L
-1
; B) powder from TFNF-DL- D membrane trial at 0.9 g.L
-1
; C) powder 
from TFNF-DL- E membrane trial at 1 g.L
-1
. The red points indicate the different peak areas and 
the label values the retention times of those peaks. The peaks without red points are the ones 
with dispersible areas (≤ 2). 
 
 It can be seen from Figure 4.7 that the samples were prepared in different concentrations. The 
objective was to prepare solutions with 1 g.L
-1
 being easier the comparison with the analysis to the 
original powder. The reason for this was that not enough powder was available due to difficulties in 
collecting the powder from the cell. 
 Comparing Figures 4.6 and 4.7, it was concluded that the powder collected was in fact 
amoxicillin. This indicates that for some reason the product of interest was precipitating during the 
diafiltration process. Nevertheless, all impurity peaks had a much lower signal area compared with the 
amoxicillin peak. Using the calibration curves in appendice I, it was possible to verify the amoxicillin 
concentration in the samples and therefore estimate the powders purity. For the samples represented 
in Figure 4.7 A) and B) was obtained a purity of 99.03% and 99.22% respectively. For the sample 
corresponding to the image C), a purity above 100% was obtained, probably due to an experimental 
error made when preparing the 1 g.L
-1
 solution. 
 MIT co-workers had observed that the compound 4-hidroxy-L-phenylglycine (impurity) tends to 
crystallize in the same conditions as the API due to their similar properties. Since the powder collected 
had very low content of this impurity, it was though that the precipitation could be due to solubility 
reasons. Concentration polarization in the membrane interface or even insufficient mixing in some 
dead areas of the membrane cell could be the reason for an increase in concentration, reaching the 
amoxicillin solubility limit. 
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 Thus, the mass transfer coefficient for amoxicillin was estimated for the diafiltration process 
performed. From the Equations III.8 to III.11, described in the sub-section 3.1.4.2.2, the approximated 
amoxicillin mass transfer coefficient in the diafiltration process was calculated, having a value of 
1.62x10
-7
 m.s
-1
, which is considerably low (standard order of magnitude between 10
-5
 and 10
-6
 in 
membrane systems). 
 Peeva et al. studied the effect of concentration polarization on flux in OSN (Peeva and 
Livingston, 2004). The model developed and the corresponding mathematical equations are described 
in sub-section 3.1.4.2.3. Defining the permeability, molal volume, rejections and feed concentration for 
the solute and solvent, it was possible to calculate the solute concentration at the membrane interface 
profile with the mass transfer coefficient in a determinate system. Using MATLAB® to solve the non-
linear algebraic Equations III.15 to III.17 and considering the results and conditions from the TFNF-DL-
E trial in the upside-down cell (vide Table 4.8), the membrane interface concentration profile of 
amoxicillin in the range of the mass transfer coefficients estimated above was obtained. 
 
 
 
Figure 4.8 – Concentration profile for the API in the membrane interface, Cim, as a function of 
the mass transfer coefficient. Profiles for the experimental trial using the TFNF-DL – E for both 
pH conditions considering a retentate API concentration of 2.74 mol.m
-3
 (1 g.L
-1
) and a solvent 
rejection of 1%. 
 
 
 From Figure 4.8 it can be seen that the concentration of the API in the membrane interface 
increases with the decrease of the mass transfer coefficient. Considering the mass transfer coefficient 
estimated previously, 1.62x10
-7
 m.s
-1
, a concentration in the range of 3 mol.m
-3
 was obtained from the 
concentration profile. Since the solubility limit in water for the API is approximately 3 g.L
-1 
(8.21 mol.m-
3) for pH 5 and 8 g.L-1 (22 mol.m-3) for pH 8.6; the increase at the concentration in the membrane 
interface described by the module is not sufficient to cause the powder precipitation.  
 As it was mentioned before, an inconstant hydrodynamic profile in the cell could be also 
causing this phenomenon. Because the stir is situated at the bottom and center of the cell, in some 
areas the mixing might not be sufficient to have a homogeneous solution. These called dead areas are 
normally situated close to the upper side and in the radial perimeter of the membrane cell. The 
precipitation powder appeared exactly in those areas, so possibly this insufficient mixing could be 
contributing to this precipitation. 
 No further investigation of this phenomenon was continued, but it seems that this precipitation 
could be crucial for the implementation of the process itself. 
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 4.3.3 Membrane screening conclusion 
 
 From all the screening trials, the TFNF-DL membrane was the most promising for the 
separation process in study showing consistency and reproducibility even when changing the set-up 
process. This membrane had the best results using higher pressures (30 bar) and achieving an API 
rejection of 99% with a very satisfactory flux of approximately 65 L.m
-2
.s
-1
. When working in basic 
conditions (pH of 8.7), it was observed, like the other studied membranes, an increase in the 
difference between the solutes rejections; a maximum difference of 10 p.p was achieved. Although it 
was possible to optimize the separation manipulating the pH conditions, the difference between the 
solutes rejections were still very similar which constitutes a hurdle to the separation process.  
 A system mass balance calculation demonstrates that to achieve a clean and efficient 
separation using diafiltration, two conditions need to be met: the difference in rejection between the 
two solutes needs to be large and the rejection of the bigger compound should be close to 100%. 
None of these conditions were achieved in the previous studies. It is common that in the field of 
membrane separation, the limiting factor is the membrane performance itself, with insufficient 
separation even after screening and optimization. It is for this reason that membrane cascades were 
originally proposed to overcome this fundamental material limitation. In the next section different 
cascade systems and conditions will be simulated and compared for the case in study. With a suitable 
cascade system possibly the issues described above can be mitigated and a separation with high 
purity and reasonable yield accomplished. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER IV – RESULTS AND DISCUSSION 
FCT-UNL 
61 
4.4 Process modelling  
 With the results obtained from the membrane screening, it was possible to simulate the 
behaviour of the separation process using different system configurations. The main goal was to use a 
cascade configuration, improving the separation process, and incorporate the system in a continuous 
process of amoxicillin purification. 
 Firstly, a simulation using a semi-batch system was conducted considering only one stage and 
then two stages. The two stage membrane cascade system was then adapted to a continuous system 
and simulated using two different configurations in the same conditions. All the different separation 
configurations were modelled by equating a mass balance for each stage. The concentration profiles 
of the product and impurity were calculated in MATLAB® using the process models described in sub-
sections 3.2.1 and 3.2.2. The concentration profiles were then used to determine the yield and purity 
profiles. Different parameters such as the feed flow rate into the system (Feedin), the stages effective 
pressures (ΔP), the recycle ratio (Rc) and feed utilization ratio (FU) were studied in detail. A three 
continuous cascade, using the most suitable continuous membrane cascade configuration, was also 
simulated in steady state using MS Excel Solver
TM
. In this way, the increase of the number of stages in 
the separation was also investigated (described in sub-section 3.2.2.2).  
 In Table 4.9 are described the parameters considered for all simulations, based on the semi-
batch experimental trial using the commercial membrane TFNF-DL-E described in Table 4.8. 
 
Table 4.9 - Summary of the parameters considerations based on the semi-batch experimental 
trial using the TFNF-DL-E membrane. 
Parameter Value considered Unit 
Effective pressure in stage 1  30 bar 
Model mixture pH 8.7 - 
Working temperature 22 ºC 
Permeability  2.14
a 
L.m
-2
.h
-1
.bar 
API rejection  99.12 % 
Impurity rejection 87.80 % 
Membrane area in stage 1  51x10
-4 
m
2
 
Membrane area in stage 2  51x10
-4
 m
2
 
Membrane area in stage 3 51x10
-4
 m
2
 
Initial concentration of API  1.00 g.L
-1
 
Initial concentration of Impurity  0.03 g.L
-1
 
Initial API purity 97.09 % 
Volume in stage 1  0.10 L 
Volume in stage 2  0.10 L 
Volume in stage 3  0.10 L 
a Correspondes to a flux average of 64 L.m
-2
.h
-1
 at 30 bar obtained after 5 h of experiment. 
 
 Two system limitations had to be considered in the simulations: for cascade systems the 
effective pressure of the following stage had always to be lower than the previous stage (ΔP1> ΔP2> 
ΔP3), to guarantee the existence of retentate flow-rate in all stages; and the amoxicillin concentration 
in the purified out stream cannot be above 8 g.L
-1
 due to the solubility limit at the workable conditions. 
This boundary condition is of great importance and can seriously affect the liability of the process 
since the fundamental concept of the system configuration is to concentrate the product of interest in 
the feed tank. These two considerations are the system restrains. 
 
 
 
 
 
 
 
 
CHAPTER IV – RESULTS AND DISCUSSION 
FCT-UNL 
62 
0 5 10 15 20 25 30 35
0
20
40
60
80
100
N
o
rm
a
liz
e
d
 M
a
s
s
 (
M
/M
0
) 
[-
]
Time [h]
 API Model - R=99.12%
 Impurity Model - R=87.80%
0 5 10 15 20 25 30 35
0
20
40
60
80
100
A
P
I 
Y
ie
ld
 a
n
d
 P
u
ri
ty
 [
%
]
Time [h]
 Yield Model
 Purity Model
 4.4.1 Semi-Batch mode 
 4.4.1.1 One stage system 
 With the configuration and correspondent mathematical equations described in the sub-section 
3.2.1 for a single stage and the considerations described in Table 4.9 a characterization of the system 
was performed using MATLAB®. 
 
A)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.9 – Single-stage semi-batch system: A) Mass profiles over filtration time for both 
compounds in the retentate stream; B) Yield and purity profiles for the API, amoxicillin. 
 
 From Figure 4.9 it can be seen that the mass of each compound remaining in the retentate 
stream followed the expected trend. A substantial decrease over time for the amoxicillin mass profile 
was observed; even if the rejection was 99% this would result in a loss of product and an accentuate 
decrease in yield. From an initial purity of 97.09%, a final purity of 99.99% could be achieved for the 
API after 35 (25 vols) but with a very low yield of 33%. The trade-off between purity and yield is too 
high limiting the purification process. 
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 Once again it can be seen that the limiting factor was the membrane performance itself, with 
insufficient separation even after screening and optimization.  
 A cascade system was then considered to further optimize the purification process. 
 4.4.1.2 Two stage system 
 With the configuration and mathematical equations described in the sub-section 3.2.1 and the 
considerations described in Table 5.1 a characterization of the two stage semi-batch system was 
performed using MATLAB®. Since the modulation was performed following the assumption that the 
rejection and permeability values were the same in both stages, a pressure of 25 bar for the second 
stage was chosen to perform the simulation and consequently a Rc of 0.17 was established. 
 
A) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.1 – Two-stage semi-batch system considering an effective pressure in the second 
stage of 25 bar and a Rc = 0.17: A) Total normalized mass profiles over filtration time for both 
compounds in the retentate stream; B) Yield and purity profiles for the API, amoxicillin, and the 
correspondent zoom. 
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 Comparing Figures 4.9 and 5.1 it can be seen a clear process optimization using the cascade 
system. After 35 h (25 vols) a purity and a yield of 99.65% and 97.86%, respectively, was achieved in 
opposite to 99.99% purity and 33% yield using a single stage system. A purity of 99.99% with a yield 
of 94.24% can be obtained but a diafiltration time of 92 h (69 vols) would be necessary, which would 
not be sustainable. 
 The effect of the recycle ratio (Rc) was also study in detail. As mentioned before, Rc is an 
independent variable that can be controlled using the back-pressure regulators, and its value can be 
adjusted from zero to as high as the membrane can withstand.  
 
 
 
 
 
Figure 5.2 – Modeled effect of recycle ratio, Rc, on the API yield and purity of amoxicillin in a 
two-stage cascade after 35 h (25 vols) obtained using MATLAB®. 
 
 From Figure 5.2 it can be seen that the Rc parameter has a significant impact in the purity and 
yield. Increasing the Rc will increase the API yield but inevitably decrease the purity.  
 Without recycling, the compounds that permeate through the first stage would accumulate in the 
second stage over time. Then, as the concentrations in the second stage increase, both compounds 
start to permeate the second membrane identically to the single-stage process, and the absolute mass 
loss increases accordingly. The reason for the dramatic improvement in yield with increasing the Rc is 
that the concentration of the compounds in the second stage is low, thus minimizing the yield loss 
through the second membrane. On the other hand, the purity decreased significantly with increasing 
Rc. When working with only a 10 p.p difference between rejections, more impurity is retained in the 
retentate stream and therefore its concentration in the feed tank will increase with the Rc. In addition, 
when increasing the Rc the concentration in the second stage is minimized slowing down the impurity 
removal rate (Kim J.and livingston, 2013). Therefore, two-stage system takes more time/vols to 
achieve the same purity as single-stage.  
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 4.4.2 Continuous mode 
 The main goal was to incorporate this separation step in a continuous industrial process. Two 
different configurations were studied in detail and will be explained in more detail in the next sub-
sections. In both configurations, it was considered that a continuous flow of the feed to be purified was 
pumped to the feed tank and the purified stream would come out of the feed tank as well; the 
permeate stream was fed to the next stage. A mathematical model describing the two different 
configurations was developed and used for preliminary selection of operational parameters. In sub-
section 3.2.2 the two configurations schemes are described as well as the correspondent 
mathematical equations; both configurations are an adaptation of the semi-batch two-stage cascade 
system presented in the previous sub-section. 
 The effect of various parameters, such as the flow rate of the feed into the tank and the 
effective pressure in each stage, was proved to be of great importance to the separation process. In 
addition, as expected, two very important parameters were also important the Rc and the feed 
utilization ratio, FU, both defined in the in sub-section 3.2.2. 
 
 4.4.2.1 Configuration I  
 In configuration I, all the retentate streams from both stages are recycle back to the feed tank 
(scheme and mathematical equations presented in sub-section 3.2.2.1). To understand the critical 
parameters and optimal conditions to work a system characterization was performed. Parameters 
such as the flow rate of the feed into the feed tank, the difference between the effective pressure of 
the two stages, the Rc and the FU were study in detail. The FU ratio parameter it is dependent on the 
feed flow rate and the purified feed flow rate used in the system. 
 
 
Figure 5.3 – Concentration profile of the API in the purified outlet stream (Feedout) obtained 
using MATLAB®, considering a ΔP1 of 30 bar and varying the feed flow rate (Feedin) and the 
effective pressure of the second stage (ΔP2) parameters. A permeability of 2.14 L.m
-2
.h
-1
.bar, an 
API rejection of 99.12% and an impurity rejection of 87.80% were used based on the TNFN-DL-E 
membrane trials. 
 
 From Figure 5.3 it can be seen that the Feedin and the difference between the stages effective 
pressures are critical parameters to the process. The amoxicillin concentration in the purified stream 
increases with the decrease of the difference between stage pressures. A pressure lower or equal to 
10 bar is necessary to obtain suitable concentrations of the API in the purified stream (which means a 
minimum pressure of 20 bar in the second stage). It was also observed an increase in the amoxicillin 
concentration in the purified stream (Feedout) with the decrease in the Feedin. With a feed flow rate of 
0.700 L.h
-1
 the maximum API concentration obtained was approximately of 2 g.L
-1
. When decreasing 
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to a feed flow rate of 0.343 g.L
-1
 or higher was obtain a concentration equal or even higher to 8 g.L
-1
. 
Concentrations higher than 8g.L
-1
 were not presented in the graph since the solubility of API at the 
assumed conditions are 8 g.L
-1
. 
 The purity and yield profiles were analyzed varying the difference between stage effective 
pressures and the feed flow rate. 
 
A) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.4 – Purity (figure A) and yield (figure B) profiles of the API in the purified outlet stream 
(Feedout) obtained using MATLAB®, considering a ΔP1 of 30 bar and varying the feed flow rate 
(Feedin) and the effective pressure of the second stage (ΔP2) parameters. A permeability of 
2.14 L.m
-2
.h
-1
.bar, an API rejection of 99.12% and an impurity rejection of 87.80% were used 
based on the TNFN-DL-E membrane trials. 
 
 Figure 5.4 shows that the highest API purity does not correspond to the lowest feed flow rate 
due to the solubility limit restriction. As observed in Figure 5.3, the tendency for better results when 
decreasing the difference between stages effective pressure was maintained. 
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 As expected the API yield profile follows the opposite trend of the purity profile, decreasing 
significantly with the decrease in the difference between stage pressures. The lower the Feedin the 
higher pressure difference can be used without compromising in a great extent the purity. 
Nevertheless, in terms of yield the pressure conditions need further investigation. 
 The Rc and feed utilization parameters (FU) profiles were also investigated.  
 
 
 
Figure 5.5 – Behavior of the feed utilization (FU) and Recycle ratio (Rc) with the difference of 
effective pressure between the two stages (ΔP1-ΔP2) obtained using MATLAB®. A ΔP1 of 30 
bar, permeability of 2.14 L.m
-2
.h
-1
.bar, an API rejection of 99.12% and an impurity rejection of 
87.80% were used based on the TNFN-DL-E membrane trials. 
 
 In the Figure 5.5 it is represented the profiles of FU (read in the left Y axis) and Rc (read in the 
right Y axis) as a function of the difference between the stage pressures. The FU increases with the 
decrease in the difference between stage pressures and in the Feedin. Therefore, to achieve higher 
concentrations of the API in the purified out stream, higher FU are necessary. This means that more 
feed is necessary to be kept in the system for the process to run effectively and will correspond to a 
lower quantity of solution coming out as purified stream. 
 The profile of the Rc was also studied and since this parameter is independent of the Feedin, it 
was only represented one profile curve in Figure 5.5. The Rc has the opposite tendency comparing to 
the FU, it decreases when decreasing the difference between the stage pressures. Therefore, to have 
higher concentrations of API in the Feedout, low Rcs are necessary, as observed in the previous semi-
batch two stages configuration. Since both compounds have a high rejection with the TFNF-DL 
membrane (only 10 p.p. difference), the separation is not so effective and more impurity is kept in the 
system when increasing the Rc, as explained in sub-section 4.4.1.2. The Rc and FU are directly 
related since both are dependent of the effective pressure in the second stage and this has to be 
considered. 
 From Figure 5.3, 5.4 and 5.5 it was possible to understand the relevant parameters and the 
limitations of the configuration. A number of simulations with MATLAB® using different combination of 
parameters are presented in Table 5.1 to evaluate the most suitable combination of parameters in 
order to perform the purification process. 
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Table 5.1 - Values for independent and dependent variables, obtained using MATLAB®, in 
order to optimize the conditions (considering a permeability of 2.14 L.m
-2
.h
-1
.bar, an API 
rejection of 99.12% and an impurity rejection of 87.80%). Boundary condition established: API 
maximum concentration = 8 g.L
-1
. 
Independent Variables Dependent Variables 
ΔP1 
[bar] 
ΔP2 
[bar] 
Feedin 
[L.h
-1
] 
API CFeedout  
[g.L
-1
] 
Impurity CFeedout 
[g.L
-1
] 
API Purity  
[%] 
API Yield 
[%] 
FU 
[-] 
Rc 
[-] 
30 22 0.310 6.68 0.16 97.63 99.83 6.69 0.27 
30 23 0.310 9.00 0.20 97.84 99.73 9.02 0.23 
30 25 0.343 7.88 0.17 97.87 99.68 7.90 0.17 
30 26 0.343 10.86 0.20 98.17 99.43 10.92 0.13 
30 29 0.500 3.27 0.08 97.60 99.56 3.28 0.03 
30 29 0.700 1.98 0.05 97.33 99.81 1.99 0.03 
 
 From Table 5.1 it can be identified the optimal process parameters taking into account the 
restrictions and conditions established. The values marked in red were excluded since the API 
concentration in the purified out stream was above the amoxicillin solubility limit. The best parameters 
combination was obtained using a feed flow rate of 0.343 L.h
-1
, a 30 bar effective pressure for the first 
stage and 25 bar in the second stage, obtaining a purity of 97.87% and a yield very close to 100%. As 
expected, the Rc a small value of 0.17 and the FU had a significant high value of approximately 8. 
Nevertheless, it can also be notice that FU has the same values as the API Feedout concentration (FU 
≈ CFeedout.). 
 Establishing the optimal process parameters, Concentration profile of API and impurity as well 
as the yield and purity for API were simulated and are represented in Figures 5.6 and 5.7. 
 
A)       B) 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.6 – Concentrations in the purified stream over time (h) obtained using MATLAB®: A) 
API profile; B) Impurity profile Parameters considered: ΔP1= 30 bar; ΔP2= 25 bar; Feedin = 
0.343 L.m
-2
.h
-1
 and a permeability of 2.14 L.m
-2
.h
-1
.bar. The recycle ratio and the feed utilization 
of the systems are respectively Rc= 0.17 and FU= 7.90 (vide Table 5.1). 
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Figure 5.7 – Profiles of the API purity and yield obtained using MATLAB®. Parameters 
considered: ΔP1= 30 bar; ΔP2= 25 bar; Feedin = 0.343 L.m
-2
.h
-1
 and a permeability of 2.14 L.m
-
2
.h
-1
.bar. The recycle ratio and the feed utilization of the systems are respectively Rc= 0.17 and 
FU= 7.90 (vide Table 4.9). 
 
 In less than 35 h (25 vols) it was achieved an amoxicillin purity of 97.80% (read in the left Y 
axis) with a workable yield of approximately 98% (read in the right Y axis), from an initial API purity of 
97.09%. The purity obtained does not yet reach the initial goal of 99.70% purity (3 ppm of impurity in 
the solution).  
 Restrictions in terms of the similarity in the rejection of solutes and API solubility limits are 
detrimental factors hindering a higher success in the purification process. Therefore, other 
configurations were studied to possibly achieve better results.  
 An increase from two to three stages was performed and analyzed in steady state using MS 
Excel Solver
TM
. Considering the results obtained in the TFNF-DL-.E trial (a permeability of 2.14 L.m
-
2
.h
-1
.bar, an API rejection of 99.12%, an impurity rejection of 87.80% and considering an effective 
pressure of 30 bar for the first stage) it was obtained a higher API yield of 99% but the API purity 
dropped to 97.45% considering a lower feed flow rate of 0.247 L.h
-1
.  
 Since the solute rejections were both very high, a high percentage of the impurity was being 
retained in the membrane as well. Therefore, it was thought that the recycle of the retentate streams 
back to the feed tank could be a configuration impediment to achieve higher purities. A change in 
configuration was considered and different options were study. A configuration where instead of 
recycling the retentate streams back to the feed tank these were recycled directly into the feed of the 
first stage (Feedcell represented in the configurations shemes). Simulations in steady state using MS 
Excel Solver
TM
 were performed and the results shown no improvement in the purity of the product. 
Considering the results obtained for the TFNF-DL-.E trial (a permeability of 2.14 L.m
-2
.h
-1
.bar, an API 
rejection of 99.12%, an impurity rejection of 87.80% and considering an effective pressure of 30 bar 
for the first stage) using a feed flow rate of 0.200 L.h
-1
, was obtained a higher API purity of 97.99% but 
the API yield dropped to 92.99%. Higher purities could be obtained but with a pronounced drop in the 
product yield. For instance to obtain a purity of 99.32% the yield would correspond to 48.84%. Finally 
it was thought to recycle the permeate streams, instead of the retentate streams, because impurity 
concentration is lower (see sub-section 3.2.2.2). Being the first stage the main responsible for the 
separation itself and since this stream switch would have a negative effect in the API yield (the 
retentate has higher concentrations of the API), it was thought to switch only the retentate and 
permeate streams of the second stage. The promising results from this configuration are discussed in 
the next sub-section. 
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 4.4.2.2 Configuration II 
 In configuration II, the permeate stream from the second stage was recycled back to the feed 
tank instead of the retentate stream (configuration and mathematical equations presented in sub-
section 3.2.2.2). To understand the critical parameters and optimal conditions to work in this 
configuration a system characterization was performed. Parameters such as the Feedin, the difference 
between the effective pressure of the two stages and, the Rc and the FU were studied in detail.  
 
 
 
Figure 5.8 – Concentration profile of the API in the Feedout obtained using MATLAB®, 
considering a ΔP1 of 30 bar and varying the Feedin and ΔP2 parameters. A permeability of 2.14 
L.m
-2
.h
-1
.bar, an API rejection of 99.12% and an impurity rejection of 87.80% were considered. 
  
 From Figure 5.8 it can be seen that the Feedin and the difference between the stages 
pressures are critical parameters to the process. The amoxicillin concentration in the purified stream 
increases with the decrease of the difference between stage pressures. Depending on the feed flow 
rate, the optimal difference between stages effective pressure changes significantly. When 
considering feed flow rates equal or higher than 0.343 L.h
-1
 the difference in pressure should not be 
higher than 7 bar, but when considering lowest feed flow rates the difference in pressures could be 
between 22 and 27 bar. It was also observed an increase in the amoxicillin concentration in the 
purified stream with the decrease of the Feedin. Considering a feed flow rate of 0.700 L.h
-1
 the 
maximum API concentration obtained was approximately of 2 g.L
-1
. When decreasing to a flow rate of 
0.100 g.L
-1
 or lowest it was possible to obtain concentration around 8 g.L
-1
 (we cannot go higher than 
this value). Higher concentrations that 8g.L
-1
 are not presented in the figure since cannot be obtained 
due to the API solubility limit in the considered conditions. 
 The purity and yield profiles were analyzed varying the difference between stage effective 
pressures and the feed flow rate. 
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Figure 5.9 – Purity (figure A) and yield (figure B) profiles of the API in the purified out stream 
(Feedout) obtained using MATLAB®, considering a ΔP1 of 30 bar and varying the feed flow rate 
(Feedin) and the effective pressure of the second stage (ΔP2) parameters. A permeability of 
2.14 L.m
-2
.h
-1
.bar, an API rejection of 99.12% and an impurity rejection of 87.80% were used 
based on the TNFN-DL-E membrane trials. 
 
 From Figure 5.9 it can be seen that the highest API purity corresponds to the lowest feed flow 
rate. As observed in Figure 5.8, the feed flow rate and the effective pressure difference between 
stages have a considerable impact in the purity and yield results. The API yield profile follows the 
opposite trend to the purity, decreasing significantly with the decrease in the difference between stage 
pressures. With lowest feed flow rates it was possible to obtained better purification results, but to be 
sustainable in terms of yield the pressure conditions have to be carefully chosen. With this 
configuration, the API yield is much more affected comparing with the previous configuration, 
especially when working with lower feed flow rates. 
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 The Rc and FU parameters profiles were also investigated and are represented in Figure 6.1. 
 
 
Figure 6.1 – Behavior of the feed utilization (FU) and recycle ratio (Rc) with the difference of 
effective pressure between the two stages (ΔP1-ΔP2) obtained using MATLAB®. A ΔP1 of 30 
bar, permeability of 2.14 L.m
-2
.h
-1
.bar, an API rejection of 99.12% and an impurity rejection of 
87.80% were considered. 
 
 Figure 6.1 shows the profiles of the FU (read in the left Y axis) and the Rc (read in the right Y 
axis) with the difference between the stages effective pressures. The FU increases with the decrease 
in the difference between stage pressures and by decreasing the Feedin. This means that to have 
higher concentrations of the API in the purified stream higher FU is necessary. As in configuration I, 
lower quantities of solution will be coming out as purified stream due to this high FU by the system. 
 The profile of the Rc was also studied and since this parameter is independent of the Feedin, 
only one profile curve is presented in Figure 6.1. The Rc has the opposite tendency comparing to FU it 
decreases when decreasing the difference between the stage pressures. But unlike configuration I, 
depending on the feed flow rate considered, the optimal value for the recycle ratio is significantly 
different. When considering feed flow rates equal or higher than 0.343 L.h
-1
 the Rc should not be 
higher than 0.2, but when considering lower feed flow rates the optimal values for the Rc are between 
0.7 and 0.9.  
 From Figure 5.8, 5.9 and 6.1 it was possible to understand the relevant parameters and the 
limitations of the configuration. A number of simulations with MATLAB® using different combination of 
parameters are presented in Table 5.2 to evaluate the most suitable combination of parameters in 
order to perform the purification process. 
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Table 5.2 - Values for independent and dependent variables, obtained using MATLAB®, in 
order to optimize the conditions (considering a permeability of 2.14 L.m
-2
.h
-1
.bar, an API 
rejection of 99.12% and an impurity rejection of 87.80%). Boundary condition established: API 
maximum concentration = 8 g.L
-1
. 
Independent Variables Dependent Variables 
ΔP1 
[bar] 
ΔP2 
[bar] 
Feedin 
[L.h
-1
] 
API CFeedout 
[g.L
-1
] 
Impurity CFeedout 
[g.L
-1
] 
API Purity 
[%] 
API Yield 
[%] 
FU 
[-] 
Rc 
[-] 
30 24 0.065 32685.05
a 
0.09 100.00 347165.47
 a
 0.00
 b
 0.80 
30 25 0.065 7.95 0.06 99.25 62.13 12.80 0.83 
30 22 0.100 13.73 0.08 99.41 56.66 24.22 0.73 
30 23 0.100 5.19 0.06 98.80 83.68 6.21 0.77 
30 4 0.343 9.90 0.14 98.62 90.67 10.92 0.13 
30 5 0.343 7.36 0.12 98.40 93.07 7.90 0.17 
30 1 0.500 3.21 0.08 97.67 97.92 3.28 0.03 
30 1 0.700 1.97 0.05 97.38 99.09 1.99 0.03 
a Values considering FU=0 but in reality FU<0 which will implicate a negative concentration in the Feedout stream 
(verified using steady state). 
b. Negative values (in the MATLAB code was defined to take the value 0) 
 
 From Table 5.2 it can be identified the optimal process parameters taking into account the 
restrictions and conditions established. The values marked in red were excluded since the API 
concentration in the purified out stream was above the amoxicillin solubility limit. The best API purity 
obtained was 99.25% but since the API yield has a poor value of 62.13% this result was also 
discarded. Considering a 30 bar effective pressure for the first stage and 5 bar in the second stage 
and a feed flow rate of 0.343 L.h
-1
, a purity of 98.40% with a satisfactory yield of 93.07% was 
achieved. As mentioned before, a lost in yield was expected but the trade-of between purity and yield 
has to be balance to obtain a suitable process. For the same conditions (Feedin = 0.343 L.h
-1
) the FU 
had a significant high value of approximately 8 and the recycle ratio a small value of 0.17, as observed 
in the previous configuration I. 
 Establishing the optimal process parameters, the concentration purity and yield profiles were 
simulated in MATLAB® and are represented in the Figures 6.2 and 6.3. 
 
 
A)       B) 
 
 
 
 
 
  
 
 
 
 
Figure 6.2 – Concentrations in the purified stream over time (h) obtained using MATLAB®: A) 
API profile; B) Impurity profile. Parameters considered: ΔP1= 30 bar; ΔP2= 5 bar; Feedin = 0.343 
L.m
-2
.h
-1
 and a permeability of 2.14 L.m
-2
.h
-1
.bar. The recycle ratio and the feed utilization of the 
systems are respectively Rc= 0.17 and FU= 7.90 (vide Table 5.2). 
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Figure 6.3 – Profiles of the API purity and yield obtained using MATLAB®. Parameters 
considered: ΔP1= 30 bar; ΔP2= 5 bar; Feedin = 0.343 L.m
-2
.h
-1
 and a permeability of 2.14 L.m
-2
.h
-
1
.bar. The recycle ratio and the feed utilization of the systems are respectively Rc= 0.17 and 
FU= 7.90 (vide Table 4.9). 
 
 In less than 35 h (25 vols), from an initial API purity of 97.09%, a purity of 98.40% (read in the 
left Y axis) was achieved with a workable yield of 93.07% (read in the right Y axis). The purity obtained 
was closer to the initial goal of 99.70% purity (3 ppm of impurity in the solution) but the loss in product 
was 5 p.p. higher comparing with the previous configuration I. 
 An increase from two to three stages was performed and analyzed in steady state using MS 
Excel Solver
TM
 to see if it was possible to achieve better results especially in terms of API yield. Due to 
the API yield limitations referenced before, in the three stage cascade only the last retentate stream 
from the third stage was switched with the permeate stream, being this one recycled back to the feed 
tank (configuration and mathematical equations presented in sub-section 3.2.2.2). The simulation of 
the different parameters is presented in Table 5.3. 
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Table 5.3 - Values for independent and dependent variables, obtained using MS Excel Solver
TM
, 
in order to optimize the conditions (considering a permeability of 2.14 L.m
-2
.h
-1
.bar, an API 
rejection of 99.12% and an impurity rejection of 87.80%). Boundary condition established: API 
maximum concentration = 8 g.L
-1
. 
Independent Variables Dependent Variables 
ΔP1 
 
[bar] 
ΔP2 
 
[bar] 
ΔP3 
 
[bar] 
Feedin 
 
[L.h
-1
] 
API 
CFeedout  
[g.L
-1
] 
Impurity 
CFeedout 
[g.L
-1
] 
API 
Purity  
[%] 
API 
Yield 
[%] 
FU 
 
[-] 
Rc  
Stage 2 
[-] 
Rc  
Stage 3 
[-] 
30 25 20 0.065 12.47 0.64 99.05 97.42 12.8 0.17 0.8 
30 15 10 0.065 12.72 0.22 98.31 99.44 12.8 0.5 0.67 
30 10 5 0.065 12.76 0.27 97.96 99.72 12.8 0.67 0.5 
30 25 20 0.069 7.49 0.12 98.65 98.54 7.59 0.17 0.8 
30 15 10 0.069 7.58 0.16 97.93 99.69 7.6 0.5 0.67 
30 5 10 0.069 7.59 0.18 97.65 99.84 7.6 0.67 0.5 
30 25 20 0.100 2.49 0.06 97.7 99.67 2.5 0.17 0.8 
30 15 10 0.100 2.49 0.07 97.33 99.93 2.5 0.5 0.67 
30 10 5 0.100 2.49 0.07 97.24 99.96 2.5 0.67 0.5 
30 25 20 0.343 1.21 0.03 97.19 99.95 1.2 0.17 0.8 
30 15 10 0.343 1.21 0.04 97.12 99.99 1.2 0.5 0.67 
30 10 5 0.343 1.21 0.04 97.11 99.99 1.2 0.67 0.5 
30 25 20 0.500 1.14 0.03 97.16 99.96 1.1 0.17 0.8 
30 15 10 0.500 1.14 0.03 97.11 99.99 1.1 0.5 0.67 
30 10 5 0.500 1.14 0.03 97.1 99.99 1.1 0.67 0.5 
30 25 20 0.700 1.09 0.03 97.14 99.99 1.1 0.17 0.8 
30 15 10 0.700 1.09 0.03 97.1 99.99 1.1 0.5 0.67 
30 10 5 0.700 1.09 0.03 97.09 99.99 1.1 0.67 0.5 
 
 
 From Table 5.3 it can be seen that the separation process could be improved with a three 
stage cascade system but in very limited conditions. Once again the values marked in red were 
excluded due to solubility limit restrictions. Considering a 30 bar effective pressure in for the first 
stage, a 25 bar in the second stage, a 20 bar in the third stage and a feed flow rate of 0.069 L.h
-1
 it 
was possible to obtain a purity of 98.65% with a yield of 98.65%. With this increase in the number of 
stages the API purity increased but more important an increase in almost 6 p.p. of the API yield was 
achieved.  
 This increase in the number of stages cannot be generalized since it will deeply depend on the 
configuration considered. Even with this third stage continuous configuration other possible switches 
of permeate and retentate streams are possible to be made and their study could show an 
improvement or not in the process purification. As observed in configuration I (sub-section 4.4.2.1) the 
increase in the number of stages it is not always favorable in this study case. 
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 4.4.3 Process modelling conclusion 
 
 The performance of the different system configurations used to purify the model mixture of 
amoxicillin and 4-hidroxy-L-phenylglycine using TFNF-DL membrane is summarized in Table 5.4. 
 
 
Table 5.4 - Comparison between the performances of the different systems configurations 
described previously. A permeability of 2.14 L.m
-2
.h
-1
.bar, an API rejection of 99.12% and an 
impurity rejection of 87.80% were considered. 
System configuration Conditions 
Purity 
[%] 
Yield 
[%] 
FU 
[-] 
Rc 
stage 2 
[-] 
Rc 
stage 3 
[-] 
Semi-batch single stage ΔP1 = 30 bar 
 
99.99 33.00 - - - 
Semi-batch two stage ΔP1 = 30 bar  
ΔP2 = 25 bar 
 
99.65 97.86 - 0.17 - 
Continuous two stage - 
configuration I 
ΔP1 = 30 bar 
ΔP2 = 25 bar,  
Feedin = 0.343 L.h
-1 
 
97.87 99.68 7.9 0.17 - 
Continuous two stage - 
configuration II 
ΔP1 = 30 bar 
ΔP2 = 5 bar 
Feedin = 0.343 L.h
-1
 
 
98.4 93.07 7.9 0.17 - 
Continuous three stage 
- configuration II 
ΔP1 = 30 bar 
ΔP2 = 25 bar 
ΔP3 = 20 bar  
Feedin = 0.343 L.h
-1
 
 
97.19 99.95 1.2 0.17 0.8 
ΔP1 = 30 bar 
ΔP2 = 25 bar 
ΔP3 = 20 bar  
Feedin = 0.069 L.h
-1
 
98.65 98.54 7.6 0.17 0.8 
 
 
 It can be concluded that the semi-batch two stage membrane system configuration was the one 
with better purity and yield results from all of the configurations proposed, achieving a 99.65% purity 
with a 97.86% in yield. 
 In all configurations it was observed a big trade-off between purity and yield. The key to a 
suitable process is to balance both parameters to achieve a considerable high purity with a suitable 
loss of yield. By changing the process configuration or by adding more stages to the cascade system it 
was possible to decrease the influence of this trade-off in the continuous configurations. It is important 
to notice that the increase in the number of stages does not always improves this separation, it 
dependents on the configuration considered. More investigation should be performed in this area to 
have a more general conclusion. 
 High FU and low Rc are required, which is not the ideal for a cascade system and can bring 
several limitations to the separation process in terms of flow rate of the purified out stream and loss of 
product due to concentration polarization problems in the membrane. 
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 OSN processes attracted a lot of attention as an alternative process for purification of APIs. 
This separation process offers unique advantages over conventional separation methods such as mild 
temperatures and can be employed for thermolabile compounds like APIs. In addition, it is energy 
efficient and can be also used for solvent recovery. This work had the objective to explore the potential 
of membrane technology in the amoxicillin antibiotic purification from the enzymatic synthesis sub-
product 4-hidroxy-L-phenylglycine with an initial concentration of 30 ppm (97.09% purity) to a value 
equal or less than 3 ppm (99.70 % purity). 
 
 Characterization studies of the main product were conducted. Solubility and stability studies 
were performed in order to choose the most suitable solvent. From four different solvents tested in 
detail, water was the one presenting better results and therefore the solvent used in the following 
studies. The API showed to be a labile compound to work with because of the low solubility and the 
fast decomposition solvents tested. A dissociation study was also performed for both compounds and 
from this analysis a route to explore the dissociation as a function of pH could be implemented in the 
process optimization. A basic pH of approximately 9 was thought to be the most promising pH 
condition to perform the filtration experiments. 
 A membrane screening using dead-end and m-CSTR measurements was performed varying 
the pressure (10, 20 and 30 bar) and pH (2, 5 and 8.7) parameters in six membrane types (PBI, PI, 
PEEK, TFNF-DL, M130 and Duramem®200). Higher pressures showed to improve the rejections and 
fluxes results and the change in the solution pH to a value of 8.7 improved the difference in the 
rejection of the solutes showing to be a crucial parameter in the process optimization. The best results 
were obtained using the TFNF-DL membrane (in m-CSTR measurements) at 30 bar and in basic 
conditions, having an API rejection of 99.12%, an impurity rejection of 87.80% and a flux of 64.4 L.m
-
2
.h
-1
 (2.14 L.m
-2
.h
-1
.bar). From the screening results one can conclude that the main obstacle for the 
purification process was the membrane performance itself, with insufficient separation between the 
compounds (a maximum of 10 p.p. was achieved).  
 With the results obtained from the membrane screening, it was simulated the behaviour of the 
separation process using different systems (semi-bath and continuous) and configurations. The 
membrane cascade configuration improved the separation process but the API solubility limit and the 
trade-off between purity and yield were serious limitations to the continuous cascade system. Feed 
flow rate, difference between stages effective pressures, FU and Rc were parameters that showed to 
have an important effect in the purification process results. High FU and low Rc were necessary 
conditions to obtain higher purities; nevertheless, further experimental investigation is needed to 
account for the concentration polarization effects. 
 A maximum purity of 99.65% with a yield of 97.86% was obtained with the semi-batch two-
stage cascade system being really close to the purity goal (99.70%). The application of a continuous 
configuration showed to be limited and conditioned. The most suitable result was obtained with the 
configuration II using a three stage cascade system. Implementing a Feedin of 0.069 L.h
-1
 it could be 
achieved a purity of 98.65% and a yield of 98.56% which is below the initial goal: 99.70%. Therefore it 
is necessary a more exhaustive investigation in terms of configuration and performed more 
experimental testes. 
 
 With this study it was demonstrated that the amoxicillin purification needs further investigation 
at different levels. In future works it is important to investigate other alternatives in terms of membrane 
cascade configuration. In addition, experimental data is required to validate the mathematical models 
developed in this research work. The amoxicillin precipitation in the membrane cell observed in this 
work should be carefully studied and taken into account since it could be of great importance in a 
system implementation and performance. The membrane cascade purification of the API is extremely 
dependent on the membrane selectivity, and further investigation related to the membrane needs to 
be performed to have a better resolution between the two compounds. The study of the model mixture 
and its interaction with the PBI membrane cross-linker could be also an important investigation in 
order to understand this phenomena and see if it is possible to improve this membrane performance. 
Being the search of the ideal membrane a very hard goal to achieve, another possible line of work 
could pass through a molecular manipulation of the molecular weight of one of the compounds using 
for example ligands (similar to the catalytic techniques). Other techniques such as molecular 
imprinting method (both API and impurity are very similar which could be an obstacle for using this 
technique) and zeolites could also be investigated for comparison or even incorporated in the 
purification process. 
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Appendix I – HPLC calibration curves 
 
 
 
 
 
 
Figure I.1 - Calibration curve for amoxicillin in water (30ºC, retentation time = 10 min.). 
 
 
 
 
 
 
 
 
 
Figure I.2 - Calibration curve for amoxicillin in water (30ºC, retentation time = 10 min.). 
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Appendix II – Calculations for the titration curves. 
 
 
Table II.1 - Derivative method finite elements - amoxicillin 
  
 
 
 
 
 
 
 
 
 
 
 
 
V NaOH 
(mL) 
pH 
(20ºC) 
Volume médio 
NaOH (mL) 
DpH/DV Média do Volume 
médio (mL) 
D2pH/D2V 
0 0 - - - - 
0.1 2.347 0.05 46.9400 - - 
0.2 2.372 0.15 0.1667 0.1 -467.733 
0.4 2.415 0.30 0.1433 0.225 -0.1037 
0.5 2.44 0.45 0.0556 0.375 -0.23407 
0.7 2.482 0.60 0.0700 0.525 0.027513 
1 2.594 0.85 0.1318 0.725 0.085193 
1.3 2.692 1.15 0.0852 1 -0.04655 
1.6 2.82 1.45 0.0883 1.3 0.002353 
1.9 2.982 1.75 0.0926 1.6 0.002685 
2.1 3.197 2.00 0.1075 1.875 0.007962 
2.3 3.715 2.20 0.2355 2.1 0.060931 
2.4 4.117 2.35 0.1711 2.275 -0.0283 
2.5 6.686 2.45 1.0486 2.4 0.365628 
2.6 7.325 2.55 0.2506 2.5 -0.31919 
2.7 8.023 2.65 0.2634 2.6 0.004926 
2.8 8.762 2.75 0.2687 2.7 0.001974 
2.9 9.9 2.85 0.3993 2.8 0.046632 
3 10.45 2.95 0.1864 2.9 -0.0734 
3.1 10.842 3.05 0.1285 3 -0.01931 
3.2 11.172 3.15 0.1048 3.1 -0.00767 
3.3 11.298 3.25 0.0388 3.2 -0.02062 
3.4 11.434 3.35 0.0406 3.3 0.000554 
3.6 11.87 3.50 0.1246 3.425 0.024518 
3.8 12.16 3.70 0.0784 3.6 -0.01283 
4 12.335 3.90 0.0449 3.8 -0.00882 
4.2 12.445 4.10 0.0268 4 -0.00451 
4.7 12.585 4.45 0.0315 4.275 0.001083 
5 12.72 4.85 0.0278 4.65 -0.00078 
5.5 12.882 5.25 0.0309 5.05 0.000598 
6 12.945 5.75 0.0110 5.5 -0.00362 
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Table II.2 - Derivative method finite elements - 4-hidroxy-L-phenylglycine 
V NaOH 
(mL) 
pH 
(20ºC) 
Volume médio 
NaOH(mL) 
DpH/DV Média do Volume 
médio (mL) 
D2pH/D2V 
0 2.35 - - - - 
0.1 2.42 0.05 1.4400 - - 
0.2 2.48 0.15 0.3933 0.1 -10.46666667 
0.3 2.52 0.25 0.1720 0.2 -1.106666667 
0.4 2.57 0.35 0.1257 0.3 -0.154285714 
0.5 2.59 0.45 0.0422 0.4 -0.208730159 
0.6 2.65 0.55 0.1145 0.5 0.144646465 
0.7 2.65 0.65 0.0092 0.6 -0.175524476 
0.8 2.72 0.75 0.0867 0.7 0.110622711 
0.9 2.75 0.85 0.0412 0.8 -0.056862745 
1 2.78 0.95 0.0284 0.9 -0.014172687 
1.1 2.86 1.05 0.0733 1 0.044912281 
1.2 2.93 1.15 0.0583 1.1 -0.01370224 
1.3 3 1.25 0.0616 1.2 0.002782609 
1.4 3.08 1.35 0.0585 1.3 -0.00237037 
1.5 3.1 1.45 0.0131 1.4 -0.032439336 
1.6 3.29 1.55 0.1239 1.5 0.073845013 
1.7 3.5 1.65 0.1261 1.6 0.001368524 
1.8 3.98 1.75 0.2737 1.7 0.086855106 
1.9 6.72 1.85 1.4795 1.8 0.66985843 
2 9.08 1.95 1.2118 1.9 -0.140876099 
2.1 9.64 2.05 0.2717 2 -0.470043777 
2.2 10.2 2.15 0.2623 2.1 -0.004467493 
2.3 10.4 2.25 0.0827 2.2 -0.081663143 
2.4 10.9 2.35 0.2094 2.3 0.055084798 
2.6 11.4 2.50 0.1976 2.425 -0.004850186 
2.8 11.8 2.70 0.1507 2.6 -0.018022792 
3 12.1 2.90 0.0983 2.8 -0.018737457 
3.2 12.3 3.10 0.0797 3 -0.006199481 
3.5 12.6 3.35 0.0839 3.225 0.001303311 
3.8 12.7 3.65 0.0315 3.5 -0.014963928 
4.2 12.9 4.00 0.0410 3.825 0.002481869 
4.7 13 4.45 0.0366 4.225 -0.001034506 
5.2 13.2 4.95 0.0263 4.7 -0.002205657 
5.5 13.2 5.35 0.0133 5.15 -0.00252264 
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Appendix III – Dissociation profiles 
 
Table III.1 - Molar percentage with pH of the amoxicillin for the pKa1 
PH (20ºC) Molar percentage - Dissociated Specie Molar percentage - Neutral Specie 
0 1.00E+02 4.47E-04 
0.28 1.00E+02 8.51E-04 
0.56 1.00E+02 1.62E-03 
0.84 1.00E+02 3.09E-03 
1.12 1.00E+02 5.89E-03 
1.4 1.00E+02 1.12E-02 
1.68 1.00E+02 2.14E-02 
1.96 1.00E+02 4.07E-02 
2.24 9.99E+01 7.76E-02 
2.52 9.99E+01 1.48E-01 
2.8 9.97E+01 2.81E-01 
3.08 9.95E+01 5.34E-01 
3.36 9.90E+01 1.01E+00 
3.64 9.81E+01 1.91E+00 
3.92 9.64E+01 3.58E+00 
4.2 9.34E+01 6.61E+00 
4.48 8.81E+01 1.19E+01 
4.76 7.96E+01 2.04E+01 
5.04 6.71E+01 3.29E+01 
5.32 5.17E+01 4.83E+01 
5.6 3.60E+01 6.40E+01 
5.88 2.28E+01 7.72E+01 
6.16 1.34E+01 8.66E+01 
6.44 7.52E+00 9.25E+01 
6.72 4.09E+00 9.59E+01 
7 2.19E+00 9.78E+01 
7.28 1.16E+00 9.88E+01 
7.56 6.13E-01 9.94E+01 
7.84 3.23E-01 9.97E+01 
8.12 1.70E-01 9.98E+01 
8.4 8.90E-02 9.99E+01 
8.68 4.68E-02 1.00E+02 
8.96 2.45E-02 1.00E+02 
9.24 1.29E-02 1.00E+02 
9.52 6.76E-03 1.00E+02 
9.8 3.55E-03 1.00E+02 
10.08 1.86E-03 1.00E+02 
10.36 9.77E-04 1.00E+02 
10.64 5.13E-04 1.00E+02 
10.92 2.69E-04 1.00E+02 
11.2 1.41E-04 1.00E+02 
11.48 7.41E-05 1.00E+02 
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11.76 3.89E-05 1.00E+02 
12.04 2.04E-05 1.00E+02 
12.32 1.07E-05 1.00E+02 
12.6 5.62E-06 1.00E+02 
12.88 2.95E-06 1.00E+02 
13.16 1.55E-06 1.00E+02 
13.44 8.13E-07 1.00E+02 
13.72 4.27E-07 1.00E+02 
14 2.24E-07 1.00E+02 
 
 
Table III.2 - Molar percentage with pH of the amoxicillin for the pKa2 
PH (20ºC) Molar percentage - Dissociated Specie Molar percentage - Neutral Specie 
0 1.00E+02 5.01E-08 
0.32 1.00E+02 9.55E-08 
0.64 1.00E+02 1.82E-07 
0.96 1.00E+02 3.47E-07 
1.28 1.00E+02 6.61E-07 
1.6 1.00E+02 1.26E-06 
1.92 1.00E+02 2.40E-06 
2.24 1.00E+02 4.57E-06 
2.56 1.00E+02 8.71E-06 
2.88 1.00E+02 1.66E-05 
3.2 1.00E+02 3.16E-05 
3.52 1.00E+02 6.03E-05 
3.84 1.00E+02 1.15E-04 
4.16 1.00E+02 2.19E-04 
4.48 1.00E+02 4.17E-04 
4.8 1.00E+02 7.94E-04 
5.12 1.00E+02 1.51E-03 
5.44 1.00E+02 2.88E-03 
5.76 1.00E+02 5.50E-03 
6.08 1.00E+02 1.05E-02 
6.4 1.00E+02 1.99E-02 
6.72 1.00E+02 3.80E-02 
7.04 9.99E+01 7.24E-02 
7.36 9.99E+01 1.38E-01 
7.68 9.97E+01 2.62E-01 
8 9.95E+01 4.99E-01 
8.32 9.91E+01 9.46E-01 
8.64 9.82E+01 1.79E+00 
8.96 9.66E+01 3.35E+00 
9.28 9.38E+01 6.20E+00 
9.6 8.88E+01 1.12E+01 
9.92 8.07E+01 1.93E+01 
10.24 6.86E+01 3.14E+01 
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10.56 5.34E+01 4.66E+01 
10.88 3.76E+01 6.24E+01 
11.2 2.40E+01 7.60E+01 
11.52 1.42E+01 8.58E+01 
11.84 8.01E+00 9.20E+01 
12.16 4.37E+00 9.56E+01 
12.48 2.34E+00 9.77E+01 
12.8 1.24E+00 9.88E+01 
13.12 6.56E-01 9.93E+01 
13.44 3.46E-01 9.97E+01 
13.76 1.82E-01 9.98E+01 
14.08 9.54E-02 9.99E+01 
 
 
Table III.3 - Molar percentage with pH of the 4-hidroxy-L-phenylglycine 
PH (20ºC) Molar percentage - Dissociated Specie Molar percentage - Neutral Specie 
0 1.00E+02 6.31E-05 
0.28 1.00E+02 1.20E-04 
0.56 1.00E+02 2.29E-04 
0.84 1.00E+02 4.37E-04 
1.12 1.00E+02 8.32E-04 
1.4 1.00E+02 1.58E-03 
1.68 1.00E+02 3.02E-03 
1.96 1.00E+02 5.75E-03 
2.24 1.00E+02 1.10E-02 
2.52 1.00E+02 2.09E-02 
2.8 1.00E+02 3.98E-02 
3.08 9.99E+01 7.58E-02 
3.36 9.99E+01 1.44E-01 
3.64 9.97E+01 2.75E-01 
3.92 9.95E+01 5.22E-01 
4.2 9.90E+01 9.90E-01 
4.48 9.81E+01 1.87E+00 
4.76 9.65E+01 3.50E+00 
5.04 9.35E+01 6.47E+00 
5.32 8.84E+01 1.16E+01 
5.6 7.99E+01 2.01E+01 
5.88 6.76E+01 3.24E+01 
6.16 5.23E+01 4.77E+01 
6.44 3.65E+01 6.35E+01 
6.72 2.32E+01 7.68E+01 
7 1.37E+01 8.63E+01 
7.28 7.68E+00 9.23E+01 
7.56 4.18E+00 9.58E+01 
7.84 2.24E+00 9.78E+01 
8.12 1.19E+00 9.88E+01 
CHAPTER VII – APPENDIX 
FCT-UNL 
97 
8.4 6.27E-01 9.94E+01 
8.68 3.30E-01 9.97E+01 
8.96 1.73E-01 9.98E+01 
9.24 9.11E-02 9.99E+01 
9.52 4.78E-02 1.00E+02 
9.8 2.51E-02 1.00E+02 
10.08 1.32E-02 1.00E+02 
10.36 6.92E-03 1.00E+02 
10.64 3.63E-03 1.00E+02 
10.92 1.91E-03 1.00E+02 
11.2 1.00E-03 1.00E+02 
11.48 5.25E-04 1.00E+02 
11.76 2.75E-04 1.00E+02 
12.04 1.45E-04 1.00E+02 
12.32 7.59E-05 1.00E+02 
12.6 3.98E-05 1.00E+02 
12.88 2.09E-05 1.00E+02 
13.16 1.10E-05 1.00E+02 
13.44 5.75E-06 1.00E+02 
13.72 3.02E-06 1.00E+02 
14 1.58E-06 1.00E+02 
 
 
 
Appendix IV – HPLC UV signals of the mixture model 
 
 
 
Figure IV.1 – HPLC UV signal from the aqueous mixture of amoxicillin (90.0% pure) and 4-
hidroxy-L-phenylglycine (99.0% pure), each one with a concentration of 1 g.L
-1
. The bold 
squares indicate the different peak areas and the label values the retention times of those 
peaks. 
 
